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ABSTRACT 
 
  Kcv is the shortest transmembrane protein across other voltage-and ligand-gated 
potassium channels, containing only 94 amino acids to form a functional K+ channel with two 
typical transmembrane domains (2TM).  Current interest in cell biology raises questions about 
how this most primitive of proteins can function, given its very simple structure.  To better 
understand the distinctive structure and function of Kcv, basic structural studies are necessary, 
especially in regard to how folding is vital to this protein’s conformation. Hence, we selected 
the Kcv as a small protein model to examine the early development of secondary structure 
during the synthesis within the ribosome throughout the tertiary structure and interaction of 
the nascent chain with the ribosomal protein L23 and signal recognition protein (SRP54). The 
research was carried out to monitor the early stages of protein folding in the 1st TM domain. 
The experimental strategy used the specific residues mutagenesis which involves these 
analysis techniques; using post-translation incorporated with the chemical modifications; 
PEGylation assay, cross-linking assay, and immunoprecipitation assay.   
 
 The experimental processes was as follows: truncated ribosome nascent chain 
(RNCs) of interest had their lengths synthesised in the prokaryotic 30S in vitro transcription/ 
translation system, the N-terminus lengths were radio-labelled with [35S]met and eventually the 
post-translation products were topologically analysed using the chemical modifications;  
PEGylation (thiol PEG-MAL reagent), and cross-linked with two selective cross-linkers, either 
cysteine-cysteine cross-linker (1,6-bismaleimidoheane; BMH) or lysine-lysine cross-linker 
(bis-(sulfosuccinimidyl)suberate;(BS3), and subsequently encompassing comprehensive 
analysis of the cross-linked products using immunoprecipitation (IP) with two desired 
antibodies; L23 and the signal recognition particle (SRP), respectively. The samples were 
resolved on SDS-PAGE gels with the autoradiography.  The PEGylation image successfully 
presented the clear PEGylated bands from 50-70aa when employing the M15L-Cysteine 
(incorporating L8C with a single methionine replacement) whereas the cross-linking assay 
using BS3 associated with immunoprecipitation assay presented the clearest bands from 50-
70 aa when using the three single lysines (K29I/K46/47M) incorporated with the single three 
methionine replacement (M15/23/26L) called ‘M15/23/26L-Lysine’. 
 
 This project proposes that the small 2TM protein, Kcv, begins to form as a folded 
structure inside the ribosome tunnel. Additionally, data from this project suggests that the 
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helical 1st transmembrane region of the Kcv could be first compacted in the ribosomal exit 
tunnel before attaching to the targeting pathway. Based on the PEGylated band from the 
PEGylation assay, the nascent chain is exported from the ribosome tunnel at approximately 
50 aa (~30aa contributed inside the ribosome; non-PEGylated), while consequent timing of 
the nascent chains interaction with L23 and SRP, which have been cross-linked and 
precipitated with the same PEGylation profile, shows that the interaction begins to be 
manifested from 50aa. These results agree with previous data for the 2TM protein (F0c) but 
are at odds with our labs analysis of larger 7TM protein (GPCR GPR35). Furthermore, the 
interaction between nascent chains, L23, and SRP54 in the ribosome exit tunnel are able to 
demonstrate a responsibility outline principle to the further cellular targeting pathway of Kcv, 
a small membrane protein which is inserted into the plasma membrane, which is the final 
destination.    
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INTRODUCTION 
 
Membrane and Membrane Proteins  
All organisms, prokaryotic and eukaryotic, present the biological membranes/plasma 
membranes, called ‘phospholipid bilayers,’ that serve as a semi-porous barrier between the 
delicately balanced inner and outer surface of the cells. The plasma membranes of animals 
are located in the outermost layer of the cell. Unlike the animal plasma membranes, most 
plants and bacteria present underneath the cell wall (Borrell et al., 2016).  Membranes are 
composed of the lipids that are amphipathic molecules, including a hydrophilic head group 
and hydrophobic tail group.  Compositions of plasma membranes are variable depending on 
species and cellular types which contain carbohydrates, proteins, and lipids held together by 
noncovalent bonds (Watson, 2015). In composition, lipids contain four distinctive groups that 
are generally exhibited in the membranes, namely glycerophospholipids, sphingolipids, 
glycolipid, and sterol (Borrell et al., 2016).  Much research evidence reveals that membranes 
play important roles in the cell, such as maintaining the balance of cells, selective transport to 
regulate substance diffusion across the cells (Karp, 2006) and equalising the ions down 
electrochemical gradients (Watson, 2015). Additionally, embedded protein receptors in the 
membranes are responsible for cell signalling or acts between cell to cell communication 
(Nugent, 2010).  
Membrane proteins are defined as being between two regions of compartments in 
cytoplasm and extracellular space. Like other proteins, the membrane proteins are 
synthesised by the ribosome and thereby subsequently associated with water as well as the 
lipids to be functions within the cellular environment (Vinothkumar & Henderson, 2010). By 
classification, membrane proteins have been grouped into two main categories based on their 
functional association with the biological membranes, including (i) integral membrane proteins 
/transmembrane proteins or intrinsic proteins that are inserted through the bilayer, and (ii) 
peripheral membrane proteins or extrinsic proteins, whereby the structural parts are not 
directly embedded into the membrane, but interact with the surface of the membranes (Cooper 
& Hausman, 2009).  It has been discovered in recent studies that membrane proteins can be 
recognised and are inserted into endoplasmic reticulum (ER) via two pathways, such as 1) 
using a conserved mechanism by signal recognition particle (SRP) and receptor for membrane 
targeting at Sec61 for translocating, and 2) a recently discovered pathway accompanied by 
different factors, including transmembrane domain (TMD), selective cytosolic chaperones, and 
assistant receptors at the ER (Hegde & Keenan, 2011).      
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Transmembrane domains (TMDs) are a part of membrane protein that generally 
exhibits as integral proteins containing a helical segment connected by cytoplasmic and 
extracellular loops (Fig. 1). Transmembrane domains are amphipathic containing both 
hydrophobic and hydrophilic regions that can orientate within the membrane. These domains 
are composed of the membrane-spanning segments of the polypeptide chain that anchor the 
hydrophobic environment interior to the lipid bilayer containing largely amino acid residues 
with nonpolar side chains. The peptide bonds are polar when they reach the environment 
without water, and most peptide bonds in the lipid bilayer enable the formation of hydrogen 
bonds with another one (Albert et al., 2002). According to transmembrane design, the 
architecture and orientation relies on a thermodynamic mechanism to prevent mismatch 
between protein and lipid membranes. (Killian, 2003) 
 
 
 
 
Figure 1: The structure of membranes; (A) the basic constitution of lipid bilayer and (B) the schematic 
representation of membrane proteins arrangement (Adapted from Wilkins et al., 2011). In comparison 
(C); a schematic illustration of transmembrane domain connecting extracellular space and cytosol by 
X-ray diffraction (data based on Deisenhofer et al., 1985). 
 
Ion Channels                              
           The evolution of all organisms has relied upon the membranes that are present to 
separate the charge and space in the cells.  Ion channels are integral proteins that are 
generated as a pore in the cell membranes that enable the passage of molecules and ions 
through the lipid bilayer (White, 1999:  Hille, 2001; Beckstein, 2004) .  To illustrate some ion 
roles in the cell, the studies found that ion channels use approximately 30 % of storage energy 
(C) 
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in the cell to operate the gradient of Na+  and K+  ions during the transition ( Ackerman & 
Clapham, 1997) .  Additionally, many studies found that the diffusion- limited rates of selective 
ions can be moved by about 107 ions per channel and per minute (Hille, 2001). Furthermore, 
ion channels help to mediate electrical signalling and regulate the ions flux as tiny voltage 
gradients across the lipid bilayers in the cells (Hille, 1992) and this electrical activity leads the 
cell to communicate between the cells ( Hille, 2001) .  Therefore, hydrophobic cores from the 
lipid bilayer are essential to provide the energetic barrier when the ions are transported at ~50 
kcal mol-1 (Parsegian, 1969). Ion channels are classified into two major classes by properties 
and mechanisms: ion permeation and gating.       
   (i) Each ion channel, e.g. Na+, K+ and Ca+ has the selective permeability 
that allows ions to be specified by name.  The substantial selectivity involves various factors 
mainly:  size, valency, and hydration energy ( Grant, 2009)  and determines the permeability 
ratio from the reversal membrane potential under biological conditions at zero net current 
(Roux et al., 2011).           
   ( ii)  The gating system is another crucial property of ion channels to 
control membrane potential by closing and opening the gate and ion passage, switching 
between the two conditions. Hence, three gating mechanisms are classified, including voltage-
dependent, ligand-dependent, and mechano-sensitive gating. The voltage-gate ion channels 
can adjust the electric conductance that correlate with the membrane potential.    Mostly, 
voltage- dependent gating generally occurs in the ion channel.  In contrast, the ligand-
dependent gating plays an important role in the cardiac ion channel.  The last gating is 
mechano-sensitive or stretch-activated channel about which we still have limited information. 
Interestingly, this ion channel can adjust an electric signal in the channel conduction ( Grant, 
2009). In spite of the many roles of ion channels, the most notable main task is responsibility 
for sending and signalling to keep the equilibrium in both closing (non-conducting) and opening 
( conducting)  states in the cells ( Minor Jr, 2009) .  The structures of ion channels can differ 
greatly in the number of the individual protein subunits or group subunits.   Generally, a 
structure of cation channels is formed by six hydrophobic transmembrane domains including 
C- terminus and N- terminus.  The pore which is generated within the central loop within the 
transmembrane domains at 5th and 6th (Bradding & Wuff, 2017).     
   However, two main typical forming ion channels have been found to be 
different.  The sodium and calcium channels comprise only a single (α) subunit which has four 
repeats of six transmembrane domains (6TMDs) per channel.  In comparison to voltage-gated 
potassium channels, voltage- dependent are generated from four separate subunits, each 
containing a single six–transmembrane domains (6TMDs) per channel (Ackerman, 1997) and 
mostly the ion channel proteins are assembled in oligomers to function ( Tabassum & Feroz, 
2011) .  Over many decades of investigation, it has been found that ion channels have very 
20 
 
high diversity and there are over 300 different types in virtually all physiological cell functions 
(Gabashvili et al., 2007). Therefore, ion channels have numerous significant roles in many cell 
mechanisms, including the regulation of water levels and hormone secretion, sensory 
systems, recognition, and behaviour (Kandel et al., 2000: Gabashvili et al., 2007).  
Potassium Channels                             
            Potassium channels (K+) are the largest family and have the most diversity located in 
cell membranes ( Hille, 2001) , known as integral membrane proteins that exist in many cell 
types, except some parasites ( Kuo et al. , 2005) .  In humans, potassium ions transport K+ 
across the membrane cellular functions, such as neuronal resting membranes, and have 
significance in the excitability of individual neurons and heart and brain tissue. Much published 
work indicates that if protein channels malfunction, it would result in serious human health and 
diseases ( Minor Jr, 2001) .  Since the potassium channel gene was first cloned from the 
Drosophila Shaker locus (Pongs et al., 1988) more than a hundred different types of potassium 
channels have been identified. These have been classified and other numerous types are still 
being discovered (Mathie et al., 2003). Thus, many different K+ channels are categorised from 
α structure and subunits in three main types including;     
  ( i) 6TMDs are the biggest class of K+ channels which contain two subclasses: 
the first is the Ca+-activated (BKKca, IKca and SKCa) and the second is the voltage-gated K+ 
with twelve sub-families (Kv1 to Kv12) (Buckingham et al., 2005). Kv is activated by changes 
in transmembrane voltage ( Gutman et al. , 2005) .  The channels are formed from six trans-
membrane domains and a single pore-forming domain.      
  ( ii)  4TMDs are a special class of potassium channels, also known as tandem 
pore domain ( K2P)  channels.  The channels present with four transmembrane domains and 
two pore-forming domains (P1 and P2). Both pores include the selective filter motif, however 
only P1 conserves the GY( F) G but not in P2 which has a different sequence of GIG or GLG 
(Kim, 2005).             
  (iii) 2TMDs: inwardly rectifying (Kir), the function is to regulate the intracellular 
factors and control the K+ ions passing into the cell from outwards (Schrempf et al., 1995). Kir 
is expressed in both states of excitable and non- excitable tissues.  Structurally, Kir has a 
fundamental structure with the two transmembrane domains, a single pore loop, N- terminus 
and C- terminus domains (Kubo et al. , 2005) .  Formed from tetramers, either hetero or homo 
were categorized into seven families ( Kir1- Kir7)  ( Hibino et al. , 2010) .  Kir channels are 
important for the functional regulation of K+ homeostasis and membrane potential in many cell 
types, mainly vascular cells, heart, brain, and pancreas (Kubo et al., 2005).   
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All three types of potassium channels ( Fig.  2)  present different structures, such as 
semi- symmetrical or symmetrical structures that mostly require four P domains per single 
channel in two transmembranes (2TMDs) and six transmembranes (6TMDs). In contrast, four 
transmembranes (4TMDs) require only two P domains (Salkoff et al., 2005).  
 
 
 
Figure 2:  The transmembrane topology, pore forming and selectivity filter among three main types of 
potassium channels, (A) 6TMDs or voltage-gate K+ channels contain six transmembrane domains and 
a single pore-forming domain, (B) 4TMDs channels/tandem pore domain (K2P) are an unusual 
structure of K+ channels containing 4 transmembrane and 2 pore domains, and (C) 2TMDs 
channels/inwardly rectifying contain two transmembrane and a single pore forming domain (Adapted 
from Buckingham, 2005). 
 
 K+  channels are highly selective, over 10,000 times more for K+  than Na+  ions ( Doyle 
et al., 1998). The selectivity can also indicate the efficiency discrimination of a protein channel 
between ions, e.g. between K+ and Na+ (Hertel et al., 2010). The central pore of K+ channels 
are predicted to have greatly higher selectivity possible due to ion interaction as well as the 
pore walls ( Hille, 2001) .   A selectivity filter might be contained in a cylindrical pore that is 
present inside the diameter about 3-3.4 Å.  The pore loop, with a signature sequence indicating 
the highly conservative K+  channels, will determine the selective filter and binding of oxygen 
dipoles.  In comparison, potassium binding sites are mostly from carbonyl dipoles from which 
the amino acid residue is derived from the signature sequence TVGYG ( Heginbotham et al. , 
1994) .  It is well known that the most typical structure of K+  channels are thought to be 
composed of two transmembranes that are associated to a single pore loop with a highly 
conservative signature sequence or consensus motif selectivity filter TxxTxG (Y/F) G, (where 
X is a variable amino acid, Doyle et al. , 1998) .   Prior studies reveal that the potassium ion 
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channels are highly encoded from viruses especially from the hosts living in fresh water 
habitats (Siotto et al., 2014). 
 
Viral Potassium Channel Kcv        
 The Kcv potassium channel is the most primitive across most K+  channels and is well 
known by the complex name of Paramecium bursaria Chlorella, PBCV- 1, genus 
Chloroviruses, family Phycodnaviridae.  The symbiotic life between green algae ( Chlorella 
strain NC64A)  in paramecium P. bursaria  containing virus to replicate Kcv ( Plugge et al. , 
2000). Thus, the study found that the PBCV-1 was the first known to encode the functions and 
the structures of a K+ channel called Kcv (Gazzarrini, 2003). Interestingly, the life of Chlorella 
is protected from lytic viral infection by endosymbiosis and without protection, the algae will 
be infected and killed rapidly (Plugge et al., 2000). As a result, the Kcv genes from the infection 
stage, present the remarkable structures and functions of K+ channels both in eukaryotes and 
prokaryotes (Thiel et al., 2011). 
     
Function of Kcv in the Life Cycle of the Virus      
  The Kcv is a package of virion that plays an important role of the virus during initial 
infection stage to the Cholorella-like green algae host.  As shown in the (Fig.3) illustration, the 
Kcv is located in the membrane of the viral particles (Frohns et al., 2006; Mehmel et al., 2003). 
The PBCV-1 initially infects the chlorella by attaching a virus vertex and fusing it to the external 
cell wall.  Eventually, the DNA genome and various proteins present in the host membrane 
( Thiel et al. , 2010) .  Apparently, the host cell is promptly charged from the process of the K+ 
conductance and depolarization.  Eventually, the K+  efflux happens according to the 
degradation of the cell wall and viral DNA is released (Wang et al., 2011). 
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Figure 3: The PBCV-1 infection stages in unicellular green algae (Chlorella NC64A) by endosymbiosis, 
PBCV-1 including capsid is attaching to the plasma membrane of the host (A), Digestion of the host 
cell wall and consequential fusion of membranes between virus and host cell results in the Kcv release 
to  the cell membrane (B), Elevated K+  conductance in the host cell leads to depolarization of the charge 
(C), and (D) membrane depolarization may help the mechanism to avoid multiple infections ( Adapted 
from Mehmel et al., 2003). 
 
Members of viral Kcv for coding Potassium Channels     
  The first known Kcv-PBCV-1 is viral, however, there are additionally three viral Kcv 
types in the family Phycodnaviridae which infect different hosts. Most viral Kcvs have the 
symbiotic life with the unicellular green algae, except for EsV1-1 which has the filamentous 
brown algae as a host (Thiel et al., 2011). The details of each Kcv is shown in Table 1. 
 
           Table 1: The member of viral Kcvs which is the code for the potassium channels. 
 
Virus types Genome size  
(Kb) 
Host Amino acids 
PBCV-1 331 Chlorella NC64A 94 
ATCV 288 Chlorella SAG3.83 82 
MT325 314 Chlorella Pb1 95 
EsV-1 336 Ectocarpus siliculosus 124 
 * (Adapted the information from Thiel et al., 2011) 
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Kcv Expression in the Heterologous Systems 
  According to functional evolution, excellent evidence shows that the Kcv channel can 
be expressed by virus replication.   In addition to that, expression of the Kcv mRNA or cDNA 
is able to form variant functions of the K+  channel as described previously, in particular Ba2+ 
sensitive in heterologous expression systems using Xenopus laevis oocytes ( frog eggs)  or 
mammalian cells, mainly HEK293 cells and Chinese hamster ovary ( CHO)  cells ( Plugge et 
al. , 2000:  Gazzarrini et al. , 2002; Kang et al. , 2004:  Gazzarrini et al. , 2009) .  In terms of 
heterologous expression systems, the Xenopus oocytes are widely employed as biological 
systems for characterisation and expression of channel proteins and other transporters from 
animals (Sigel, 1990).  Further, the Kcv protein also can be expressed in vitro, or through the 
over expression in a eukaryotic system, as well as being able to be successfully purified and 
functionally reconstituted into an artificial lipid bilayer at a single channel level (Pagliuca et al., 
2007; Shim et al., 2007). 
 
Kcv Structure and Function 
  Apparently, the viral Kcv channel presents all its structures in resemblance to the 
typical pore module of all K+ channels. Tetramer function is formed by the Kcv that also 
presents itself in other typical K+ channels, including gating, selectivity to voltage and 
susceptibility to K+ channels blocker, such as Ba2 (Plugge et al., 2000: Gazzarrini et al., 2009) 
and other complex eukaryotic channels (Shim et al., 2007).  In contrast to other viral K+, Kcv 
is a miniature sized protein that has a similar structure to the bacterial K+ channel (KirBac1.1) 
that contains the longer length of 333 amino acids (Kuo et al., 2003). To illustrate both of these 
two structures, the schematic is shown in (Fig. 4). The Kcv channels are modulated by two 
transmembrane domains, TM1 and TM2 with a pore region between two domains that are 
linked by a P-Helix (Tayefeh et al., 2009: Hertel et al., 2010). This typical structural formation 
of two transmembranes presents a filter region bearing and the sequence TxxTxGY/FGD (Fig. 
5), an extracellular turret, and short twelve amino acids (12aa) at N-terminal domain, that form 
a short helix (Tayefeh. 2007b). The Kcv channel is predicted to terminate at either the TM2 at 
the C terminus of cis-membrane (Gazzarrini et al., 2002), or in this part is totally merged into 
the lipid bilayer (Braun et al., 2013). 
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Figure 4: Tetramoric potassium channels; (A-Blue) represents the similarity between structures of 
KirBac-Kcv and Kcv-PBCV-1 in two opposite sides. The images were created by MOLCAD (Thiel et al., 
2011); (B-Green) illustration showing details of structures and functions of Kcv (Tayefeh et al., 2009). 
 
 
 
 
 
  
 
 
 
 
The Ribosome 
               In all living cells, proteins are produced on the ribosome at the peptidyl transferase 
centre (PTC). It is well known that the ribosome is an “intracellular nanofactory” responsible 
for translation and the production of nascent polypeptides by addition of amino acids (Green 
& Noller 1997). In regard to ribosomal structure, the bacterial ribosome consists of two 
subunits, a small 30S subunit and a large 50S subunit which in association make up the 70S 
ribosome (Ramakrishnan et al., 2002; Seidelt et al., 2009). Similarly, the eukaryotic structure 
contains two subunits; a small 40S subunit and a large 60S subunit but they are much larger 
and more complex than the prokaryotic structures, formed as the 80S ribosome (Ban et al., 
Figure 5: The typical Kcv topology with a 2 TM-type. The pathway of ion conduction is established by 
signature sequence “TXGXGD” representation between the two C-Terminal transmembrane domains 
(modified from Tayefeh, 2007a) 
 (A) (B) 
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2000; Carter et al., 2000; Wimberly et al., 2000; Schluenzen et al., 2000; Wilson & Daudna 
Cate, 2012). The RNA present in two ribosomes; (i) prokaryotic ribosome, the small 30S 
subunit consists of 16S RNA and the large 50S subunit comprises two RNAs; 58 RNA and 23 
RNA, and (ii) the eukaryotic ribosome, the small 40S subunit contains an 18S RNA and the 
large 60S subunit presents three RNA; 5S RNA, 5.8S and 28S RNA (as shown in Fig. 6).  
Despite difference in size and some components, the process of protein synthesis of 
prokaryotic cells and eukaryotic cells are likely to have the same main processes; initiation, 
elongation, and termination (Berg et al., 2002). 
 
      
 
 
 
 
 
 
 
 
 Figure 6: The schematic of the ribosome structure; (A) represents the function and structure of 
prokaryotic ribosome, including the small ribosomal subunit (30 S), the large ribosome subunit (50S). 
Comparison between the two subunits is the PTC, which includes tRNA and the elongating nascent 
chain (Adapted from Christodoulou Group Website, 2016), and (B)  illustrates(the function and structure 
of eukaryotic ribosome containing the small subunit (40S) and the large subunit (60S). 
 
(A) 
(B) 
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Prokaryotic Protein Synthesis 
The translation is the final step of the gene expression from the mRNA to the protein 
(Huang, 2011).  In prokaryotes, the process that starts during transcription takes place inside 
the cell. The complex initiation is formed on the 30S small ribosome subunit that requires 
essential factors to achieve the process – referred to as ‘three intermediary complexes’- these 
being the beginning phase, including (i) aminoacylated and formylated initiator tRNA (fMet-
tRNAfMet), (ii) mRNA, and (iii) the three factors (IF-1, IF-2, and IF-3) (Laursen et al., 2005).  
Convincing demonstration suggests that all IFs members play essential roles for supporting 
translation initiation more accurately and faster (Hartz et al.,1989). At the beginning of the 
process, IF-3 has initial contact with the binding site at the small subunit, where it can explain 
the anti-association effect and dissociation of the ribosome. In addition to that, IF-3 presents 
a two-model protein that is thought to select the fMet-tRNAfMet as well as correct the starting 
codon (Hussain, 2016). IF-3 allows IF-1 to bind to the ribosomal A-site and subsequently 
translocate to the initiator tRNA to the ribosomal P-site (Petrelli et al., 2001).   Previous studies 
suggest that binding between IF1 and A-site of the small subunit (30S) is predicted to move 
the tRNA in order to associate with the ribosomal P-site by hampering the ribosomal A-site 
(Carter et al., 2001). The initiation factor (IF-2) is a GTPase binding site that stimulates the 
fMet-tRNAfMet binding to the small ribosomal (30s) as a ternary complex IF-2 GTP fMet-
tRNAfMet.GTPase which leads to binding in the ribosomal P-site (Milon et al., 2010; Lockwood 
et al., 1971). Hence, IF-2 is the last factor to post fMet-tRNAfMet in the ribosomal P-site of the 
large subunit (70S) and when the dipeptide formation has initially formed, the IF-2 is also 
gradually dissociated from the ribosome (Gualerzi et al., 2001).  Finally, IF-3 next binds to the 
ribosomal E-site due to the prevention mechanism of association with the large subunit (Dallas 
& Noller 2001)  In addition to that, the initiation process of the prokaryotic translation from the 
mRNA to the proteins, the purine rich sequence (Shine-dalgarno) is present in the 5’ region of 
the mRNA that is located between 5-8 base pairs (5’-ACCUCCUUA-3’) upstream AUG (Shine 
& Dalgano, 1974). Evidence reveals that the 30S initially binds with the Shine-dalgarno 
sequence near to the AUG starting codon that is complementary to the 3’ end of 16S RNA 
(Gualerzi & Pon, 1990). At this point, the translation pathway undergoes trough elongation, or 
termination unless it obtains protein or recycles some of the imperfect proteins (Fig. 7). 
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Figure 7: The overview of the protein synthesis of prokaryotic cells. The cartoons show the four steps 
of the protein synthesis and the ribosome function during the process.  Association of intermediate 
complexes involved in the pathway; tRNA, mRNA, IFs, and GTP interaction ( Adapted from Hershey     
et al., 2012). 
 
Eukaryotic Protein Synthesis        
 In contrast to the prokaryotic translation pathway, eukaryotes have some beginning 
genetic codes and special aminoacyl-tRNAs and their synthetase. Generally, the translation 
takes place on the ribosome where the eukaryotic ribosomal two main subunits are present. 
These are larger in size than the prokaryotes and named; 40S subunit and 60S subunit 
(Wilson & Daudna Cate, 2012).  However, the mechanism of ribosome coordinates to mRNA 
as well as the initiating site, are totally different. Prokaryotic mRNAs are bound to the ribosome 
due to base pairing while the eukaryotic mRNAs are matched by a codon scanning method 
(Kozak, 1999). The eukaryotic protein synthesis is relevant to the protein complex factors in 
which there is apparently sequential utilisation in each main step, including, initiation, 
elongation and termination (Merrick et al., 1997).  The translation is the biogenesis for 
converting the mRNA to protein by association to the ribosome. First, the 40S subunit of the 
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ribosome is bound with mRNA to form the 40S-mRNA complex and the 60S subunit is formed 
as the 80S-mRNA. Although AUG is the initiating translation codon in all eukaryotes, the 
eukaryotic mRNAs do not contain a purine rich sequence/binding sequence on the 5’ end like 
in prokaryotes. When the 40S subunit binds to the cap 5’ mRNA, the nearest start codon AUG 
is searched by scanning stepwise through the 3’ direction.  The rapid scanning process 
requires energy in the form of ATP.          
  Earlier studies show that energy is obtained while the tRNA anticodon is 
inducing conformational change in the ribosomal A-site (Rastogi, 2002; Allnér & Nilson, 2011).  
The met-tRNA facilitates initial anticodon binding with AUG, the methionine codon which is 
the most common start codon in most eukaryotic proteins.  The initiation of the protein 
synthesis always begins with a methionine. The important initiating factors of eukaryotes 
involve nine factors which have different subunits. Eukaryotic initiation factors have the prefix 
named elF. The factors have been defined by their functions. The elF2 induces met-RNA 
binding with the 40S subunit and promotes binding of anticodon to the mRNA codon. The elF2 
and elF3 are incorporated in the initiation process to enhance the binding of met-tRNA and 
mRNA located nearest to the 5’ end (Rastogi, 2002; Mayeur et al., 2003).  The elF4 acts as 
the energy protein that possesses ATPase and RNAhelicase activities (Rastogi, 2002; Svitkin 
et al., 2001). The elF5 stimulates the releasing of elF2 and elF3, the pairing of met-tRNA with 
the start codon AUG. Upon this step, elF5 forms the complex with elF2 to trigger the GTP-
binding protein. Finally, the 60S subunit is associated with the complex of tRNA, mRNA, and 
the 40S subunit. The elongation and termination of the synthesis, the chain termination is 
released from only one single factor ‘eRF’ that can recognise all of the three stop codons; 
UAA, UAG, and UGA (Rastogi, 2002; Chavatte et al., 2003). 
 
Cell Free Protein Synthesis (CFPS) System      
 Cell free protein synthesis (CFPS) is termed in biological technology as the activation 
of protein production systems without utilisation of any living cells (Hodgman & Jewett, 2011). 
The cell free protein synthesis is becoming widely used as an advantageous cellular base tool 
that can establish highly efficient protein production over many decades. The technology has 
been developed inspiring the research work to have better understanding of the protein 
pathways; such as transcription and translation (Carlson et al., 2012).  According to the 
timeline of the technological invention system, the basic concept of the CFPS relies on the 
sequence processes; first bacteria is grown, the cells are harvested, and then undergo lysis. 
(Swartz et al., 2012). Recently, the basic process is one of CFPS systems that were 
established as a standard protocol for protein production, including cell culture, cell lysis, 
centrifugation, run-off reaction, dialysis, and centrifugation. E.coli S30 extract is used as the 
30 
 
basis for the CFPS system that provides an ensemble of components from the crude cell 
lysates. This cellular lysate is composed of active enzymes and auxiliary factors that are 
essentially used during the protein synthesis processes; transcription, translation, and protein 
folding (Kwon & Jewett, 2015). According to much published work, it has been revealed that 
protein folding in vitro systems of either E. coli 30 extract or wheat germ extract prevent the 
hydrophobic region of the target protein from other unwanted factors by providing an optimised 
natural environment. Additionally, there are various useful supportive aspects to in vitro folding 
systems; associating co factors (ion-sulfur groups), promoting formation of disulfide bond, and 
disulfide bond isomerization (Kim & Swartz, 2014; Carlson et al., 2012). 
 
Proteins Targeting Pathway of the Nascent chain     
 After being newly synthesised, assistant factors actively associate nascent 
polypeptides targeting the correct localisation, such as ribosomal proteins, signal recognition 
particle (SRP) and other intermediate complexes. 
 Ribosomal Protein         
  Since being discovered over 40 years ago, there has been a lot of speculation 
about the role of the diversity of ribosomal proteins. However, the definition is based on the 
proteins located within the ribosome or on the ribosomal RNA (Korobeinnikova et al., 2012). 
The studies show that the location of the ribosome can be related to the biogenesis steps or 
translation within the ribosome (Ferreira-cerca et al., 2005). The ribosome tunnel of bacteria 
comprises a tunnel, which is formed by 23S RNA containing the segment of ribosome proteins 
L4, L22, and L23.  As shown in (Fig. 8) the L23-RNA complex is situated in the A-site domain 
of the peptidyl transferase centre (PTC) (Vester & Garret, 1984).  If measured, a constriction 
region in the ribosome is approximately 30 Å from the PTC. At that point through the rim of the 
ribosome, there are the conserved ribosomal proteins, including L22, L23, L24. and L29 
(Kramer et al., 2009). Ribosomal protein L23 is a primary protein from the ribosome of 
Escherichia coli (Fig. 8), that has been used for cross-linking in the study of puromycin for 
many decades (Vester & Garret, 1984).  L23 is present at the large unit (50S) of the ribosome 
near the exit tunnel (Fedyukina & Cavagnero, 2011).  Much published work has been carried 
out with ribosomal proteins and findings reveal the interaction they have to the co-translation 
factors (SRP) at the exit tunnel (Ferreira-cerca et al., 2005).  Furthermore, it was found that 
L23 is important for E. coli growth as well as being responsible for Trigger Factor (TF) in the 
ribosome (Kramer et al., 2002).  
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Figure 8:  The contribution of ribosomal proteins at the large unit of the prokaryotic ribosome which is 
close to the ribosome exit tunnel. 
 
Signal Recognition Particle (SRP)       
  The Signal Recognition Particle (SRP) plays a significant role to intermediate 
the newly synthesised membrane protein to the endoplasmic reticulum (ER) membrane during 
the translation process (Keenan et al., 2001). This process is known as translocation. The 
SRP is an abundant cytosolic ribonucleic protein/protein-RNA complex present in variant 
composition across cellular organisms (Lütcke, 1995; Keenan et al., 2001; Nagai et al., 2003). 
Throughout all species, SRP have a universal conserved function and consist of two essential 
components: the SRP54 protein and SRR RNA (in bacteria; Ffh and 4.5S, respectively (Walter 
& Blobel, 1981).  As shown in (Fig. 9), the SRP54 (Ffh) comprises three domains, such as the 
N domain (α-helical domain), the G domain (GTP binding region that together with GTPase), 
and the M domain (methionine rich/α-helical domain). The M domain consists of a hydrophobic 
groove that serves as a signal sequence binding site and α helix turn-helix motif that binds the 
4.5S RNA (Luirink et at., 1994). A homolog, SRP54/Ffh known as 54kDa/48kDa proteins, also 
share a similar sequence and a similar structure and function (Bernstein et al., 1993). 
Therefore, both homolog proteins are being used to determine extensive protein interaction 
and targeting that can reveal the process of cell adaption and evolution.  
 
100  Å  
 
32 
 
 
 
 
 
 
 
 
 
 
 
Figure 9:  Structure, localisation and distinct domains of SRPs between E.coli (prokaryotic cell) and   
H. sapiens (eukaryotic cell) (Adapted from Nagai et al.,  2003) 
 
  SRP Function as the Protein Targeting Pathway    
  All cells absolutely need a transport system for co- or post-translational 
targeting of secretory proteins to the right location (Luirink & Sinning, 2004). Following the 
nascent polypeptides synthesis from the ribosome, the signal recognition particle (SRP) or a 
ribonucleoprotein complex will target the ribosome-nascent chain complexes to the 
translocation site (Beckert et al., 2015). At this point in both prokaryotes and eukaryotes, the 
nascent chain will be delivered through the protein biogenesis pathway in the vicinity of the 
endoplasmic reticulum (ER) and are linked to their final destination in the extracellular space 
in the plasma membrane. The ER is an organelle that is located in the intracellular space 
where the protein folding and assembly is (Luirink & Sinning, 2004; Zhang & Kaufman, 2006). 
Generally, a translocation process happens when the ribosome associates with the nascent 
chains, then the protein is translocated into the translocon site at the ER of the cell.  
Furthermore, the important auxiliary process, RNC-SRP/SR complex is regulated by GTPase 
which is present in SRP and SR.  Thus, the conformation will be changed from inducing the 
interaction with the ribosome (Luirink & Sinning, 2004).  The folding event recognises a signal 
peptide by the SRP-RNA-protein complex (called cargo) that provides the conserved 
mechanism for targeting the hydrophobic sequence at the N-terminus site of nascent 
polypeptides, when the nascent chain emerges beyond the exit ribosome tunnel (Duadna & 
Batey, 2004).  However, in addition to the above, the RNC/SRP-SP will be transported to 
translocon ER membrane targeting Sec61p (Eukaryotes), or SecYEG (Prokaryotes), where 
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variant Sec(x) refers to the complex in the ER-membrane. Upon the biogenesis pathway, when 
the RNC is delivered to the Sec61p or SecYEG site, the nascent polypeptides can either 
combine into the lipid bilayer or translocate to the secretory pathway (Akopian et al., 2013). 
The sample overview of the protein targeting is shown in (Fig. 10). 
 
Figure 10:  The schematic pathway of the SRP mediates the ribosome nascent complex to the 
translocon SecYEG in prokaryotes or Sec61p in Eukaryotes. The sequence pathway passes through 
the ER and finally targets the biological membrane (Adapted from Akopian et al., 2013). 
 
Protein Folding  
              Protein folding is the bioprocess whereby the functional structural formation from the 
polypeptide chain (linear polymers) folds into a three-dimensional structure. The initial process 
is to embed the integral part onto the biological membrane thermodynamically in the most 
stable state. Recently, much published work has determined the folding process as well as 
the elucidation of the many questions about how proteins still maintain their native state. 
Therefore, folding is commonly studied by isolating proteins in different states of solution such 
as in a diluted aqueous condition, and in a state of equilibrium. This allows the study of 
relaxation kinetics following perturbations, including the use of chemical denaturants, 
temperature or pressure (Booth, 2003; Woudby et al., 2013). The protein will be folded from 
an unfolded form to fold by itself (Williamson, 2012). Co-translational protein folding is an area 
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of increasing interest. The folding of proteins occurs after the polypeptides leave the ribosome, 
and interact with auxiliary factors. This is very important for membrane proteins, especially the 
intrinsic hydrophobic properties which still require further research. Many published papers 
suggest that the membrane proteins establish their tertiary structure by successfully co-
translationally inserting into the membrane. However, secondary structure formation is not 
well understood. In regard to the timing of the folding process, the protein sequence is folded 
very rapidly. The exact timing of secondary and tertiary folding is critical for the prevention of 
mis-folding proteins. Hence, protein mis-folding is thought to degrade polypeptide chains 
(Cabrita et al., 2010). As a result, predictions about the protein folding process of ribosomes 
can be made. Many researchers have studied the nascent chain formation from the peptidyl 
transferase centre (PTC) through the ribosome tunnel which accommodates the peptide chain 
depending on their formations, such as a fully extended nascent chain of approximately 25 
residues and fully folded structure (α-helical) at roughly 50-60 residues (Voss et al., 2006; 
Seidelt et al., 2009; Bhushan et al., 2010).  Fluorescence study (Mario et al., 2016) shows the 
possible concept of the small protein folding event inside or outside the E.coli ribosome in 
different residues, formations, and ribosome destinations (Fig. 11).  This gives rise to 
questions about whether protein folding happens inside or outside the ribosome. However, 
when the nascent chains leave the ribosome they must be directly associated to the cellular 
mechanism. Review of literature suggests that the folding process needs associated-
complexes when they present the activity in the intracellular cells, that the environment might 
be very crowded by the assembly proteins. Therefore, the factors during co-translation and 
targeting are very important for proteins (Zhou, 2013).  The auxiliary protein folding will be 
mentioned below. 
  
 
 
 
 
 
 
 
 
Figure 11:  Conceptual folding inside or outside the E. coli ribosome tunnel by translation in vitro and 
in vivo of fluorescence intensity at each SecM length (Mario et al., 2016)     
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Kcv Nascent Chain Integration into the Membrane   
    Watson et al., (2013) show that the Kcv nascent peptides are synthesised in the 
ribosome as general proteins and co-translate to the endoplasmic reticulum (ER) via the 
Sec61 translocon. The secretory containing hydrophobic transmembrane domains are 
laterally inserted into the membrane (phospholipid bilayer) to form the Kcv ion channel, by 
initial integration of N-terminus which is translocated to N-glycosylation machinery in the ER 
lumen at the Sec61 complex. Consequently, transmembrane domains in the nascent chain 
are able to orient their conformation within the optimum conditions in ER to obtain an inherent 
structure.  The study found that the orientation can occur in both in vitro and in vivo systems.  
Gebhardt et al., (2011) demonstrates that the membrane is achievably anchored and interacts 
with the Kcv viral channels to function as an ion channel by the two putative transmembranes 
model.  The experiment findings show that, at the upper halves both TM1 and TM2 interactions 
with the external region are more rigid, while the lower parts are softer. The outer two 
transmembranes rigidity can be described by the aromatic acids that are connected to the 
membrane. The experiment shows the potential integration of transmembrane domains into 
the bilayer. Both inner transmembrane domains are linked together with the rigid outer 
transmembrane domain by a pair of aromatic acids. 
 
Force Maintaining the Proteins Structure After Folding    
 In proteins, the primary structural connection between amino acids are relative to the 
strong covalent peptide bonds that link a disulphide bond whose covalent bonds combine with 
the side chain. Basically, two cysteine residues are required to form with the sulfur atom of the 
thiol group (-SH) for a disulfide bond which is conserved among the proteins. Many studies 
suggest that the disulfide bond plays a crucial role in proteins, for example, structures and 
functions.  Furthermore, the most significant factor of proteins structural-stabilising is from the 
forces that are very relevant from the basic hydrophobic interaction to the electrostatic salt- 
bridges (Thangudu et al., 2008; Dombkowski et al., 2014). 
 Hydrophobic interaction        
  Early studies found convincing evidence that hydrophobicity is a vital factor for 
protein stability in the folded configuration of many native proteins (Kauzmann. 1959; Pace et 
al., 2011). Greater understanding of hydrophobic evidence is the contribution of a nonpolar 
side chain. Thus, the stability involves two main factors; hydrophobicity of the side chain and 
the touching surface which contacts the water during protein folding, and the other is the van 
der Waals interaction of the side chain after protein folding or unfolding (Yutani et al., 1987; 
Pace et al., 2011). In addition, previous experimental studies explained why there is 
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approximately 80% of hydrophobic residue buried inside the protein core (Lesser & Rose, 
1990).  
 Van der Waals force         
 van der Waals energy is electrostatic interaction of fixed or induced dipoles. The 
interaction tends to arise most frequently among residues of polarisable chains whose 
residues refer to methyl or methylene groups. Basically, the van der Waals interactions are 
more likely to deal with the aromatic hydrophobic residues (Petsko & Ringe, 2004). Previous 
studies suggest that van der Waals interactions make an important contribution to the stability 
of the protein because non-polar groups are hidden.  Interaction between non-polar residues 
has led to contribute to increased energy within molecules (Pace et al., 2014).  The van der 
Waals energetic contribution are 8-16 Kj/mol which is the weakest force of the protein 
stabilisation (Lins & Brasseur, 1995; Petsko & Ringe, 2004).  Additionally, the van der Waals 
energy resembles the roles played by the H-bond due to energetic association for protein 
stabilisation (Cross, 2013 unpublished).   
 
 Hydrogen bond (H-bond)        
 The hydrogen bond ( H- bond)  is one of the most important forces containing 
electrostatic properties ( dipole- dipole) .  The interaction occurs when a hydrogen bond is 
shared between proton donor (N, F or O)) and proton receptor (Pauling, 1960; Cross, 2013). 
This intermediate interaction of H-bond plays a critical role in specification and direction to the 
hydrophobic and hydrophilic transient structures (Hubbard & Haider.  2010). The H-bond is of 
prominent significance in forming the secondary structures of α helix and β sheet that most 
proteins are composed of.  Thus, the H- bond force can be a determiner and immobilizer of 
protein folding when its secondary structures are associated with and distributed to the tertiary 
structure (Bordo & Argos, 1994). In addition, the kinetics and energy of the H-bond make an 
optimum interaction in the folded structure (Hubbard & Haider, 2010). 
 
 Salt-bridges          
 The role of salt-bridges in protein stabilisation is still unclear, despite a lot of research 
over the last decades. The basic problem is from the variation of salt-bridges depending on 
the ionization of the participating groups that are influenced by protein environment as well as 
other reflections, including thermal fluctuation and their life cycle which comes from the 
flexibility of the protein (Karshikoff & Jelesarov, 2008). However, convincing evidence reveals 
that the salt-bridges interaction occurs between the opposite charged side chains that are able 
to form the interaction with H-bonds. Regarding the salt-bridges formation, in general proteins 
37 
 
side chains possess the amino acids positive charge, such as lysine and arginine that can 
form the salt-bridges with the anionic residues; glutamate or aspartate side chains (Dill, 1990). 
At present, experimental findings have confirmed that salt-bridges play an important role in 
protein folding as a thermodynamic stabilisation force (Meuzelaar et al., 2014). 
 
PEGylation Assay          
    In the present study, the PEGylation assay is being used for protein modification, in 
order to investigate the Kcv secondary structures inside the ribosome. We will introduce a 
mass-tagging strategy of the nascent polypeptide to detect the folding event at the exit side of 
the ribosomal tunnel, when nascent chains emerge from the exit tunnel and then methoxy-
polyethylene glycol maleimide (PEG-MAL) containing a large molecule (5kDa) can be 
attached to the cysteine residues. As shown in (Fig. 12), upon the PEGylation reaction, the 
PEG-MAL reagent allows thiol groups of “free” cysteine residues to conjugate to determine 
the formation of the folded intramolecules. (Doherty et al., 2005). Based on the PEGylation 
principle, if a cysteine resided within the ribosome tunnel then PEG-MAL is highly inaccessible 
compared to a cysteine outside the tunnel (Lu & Deutsch, 2005). Preliminary experiments 
have shown that PEGylation is working effectively with this protein, and that the first TM 
domain forms the secondary structure within the ribosome tunnel. The protocol of studying 
channel structure and function recommends that the treatment of PEG-MAL (PEGylation) will 
PEGylate or shift in size of molecular weight by approximately 10 kDa (Robinson et al., 2006). 
 
Figure 12: The PEGylation assay reactions; (A) represents PEG-MAL conjugate C-S bonding with a 
marker cysteine when a nascent chain is released from the ribosome and is successfully PEGylated, 
and (B) In comparison, the marker cysteine buried inside the ribosome tunnel without the PEGylation 
due to inaccessibility of PEG-MAL (Modified from Zhang et al., 2016). 
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Cross-linking Assay  
  Cross-linking assay is a chemical process that combines two or more molecules by a 
covalent coupling. Modification of cross-linking technique is thought to arise from the chemical 
reaction with the specific functional groups within the proteins (Hemaprabha, 2012). Recently, 
this technique is more preferable and more likely to be used, including identifying protein-
protein interaction and detecting interaction of proteins within the ribosome subunit. Currently, 
this approach is being used for determining the region of ribosomal RNA.  Ideally, the 
posttranslational proteins are treated with the cross-linker reagents conjugated with the 
specific amino acids which are bound with either the same or different proteins, such as bis-
methyl suberimidate (BS3) which combines lysine-lysine and results in amine-amine linkage. 
Another example of a cross-linker is bismaleimidohexane (BMH) that can form a covalent 
bond between cysteine residues and target sulfhydryl-to-sulfhydryl formation. In most cross-
linking techniques, the specific molecules are led to form the covalent bonds between proteins 
(Wittmann.1976). Therefore, the cross-linking reaction is a more likely interaction in both 
neighbour surface hydrophilisation and enhancing surface hydrophobicity of proteins. Using 
experimental strategies, the cross-linking method will be achieved according to various 
important factors, such as; natural stabilisation, spanning, and targeting position of the 
crosslinks (Tyagi & Gupta, 1998). Regarding the folding and assessment of proteins, 
technology has been extensively developed and used for many decades in various chemical 
modifications (Wittmann, 1976).  Hence, this project, cross-linking is one of the selective 
approaches to be used for detecting the protein from the secondary to tertiary structure. 
 
Project Objectives: 
1) To analyse the earliest in vitro folding event of Kcv within the ribosome exit tunnel from 
the secondary to tertiary structure especially in the first transmembrane domain. 
2)  To scrutinise the influence of some amino residues, such as cysteine, lysine, and 
methionine mutagenesis of Kcv on the initial folding. 
3) To distinguish the Kcv topological structure formation from different chemical 
modifications and the radio-labelling technique. 
4)  To investigate the interaction of the nascent chain, ribosome, and protein targeting 
pathway (SRP54 and L23).  
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MATERIALS AND METHODS 
 
Escherichia coli Strains         
 The E.coli strains used in this project are as follows:           
     1. C41 competent cell:  F-ompT hsdSB (rB-mB-) gal dcm (DE3)   
     2. DH5α™ Competent cells:        
       F–Φ80lacZΔM15Δ (lacZYA-argF) U169 rec 1 endA1 hsdR17-      
        (rK–,   mK+) phoA supE44 λ– thi-1 gyrA96 relA1   
                                                  
Plasmid Vector          
 pTrc99A is a bacterial expression vector with a lacI promoter which was induced by 
isopropyl-β-Dthiogalactopyranoside (IPTG). This plasmid contains ampicillin resistant genes 
which act as a selectable marker as well as containing a multiple cloning site which is useful 
for restricting enzyme cutting and cloning as shown in (Fig. 13).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Plasmid mapping of pTrc99A, restricting enzymes and ampicillin resistant gene. 
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Transformation           
  The Kcv gene; cysteine engineered (L8C) and wild type gene sequence were 
constructed into the pTrc99A as a vector. 1 µL of each plasmid DNA was added with 100 µL 
of the competent cells DH5α E.coli  into a sterile eppendorf and then incubated on ice for 15 
minutes. The cells were heat shocked for 2 minutes at 420C and placed on ice again for 5 
minutes. After that, 1mL of autoclaved media; Lysogeny broth (LB) was then added to the 
components and mixed in a shaking incubator at 37oC for an hour, followed by spinning the 
cells at 7,000 rpm in the microcentrifuge for 5 minutes, then 800 µL of the supernatant was 
removed. The remaining cells were streaked onto the sterilized LB/Ampicillin plates and the 
plates were then left on the bench for 10 minutes. Finally, the transformed plates were placed 
upside down for incubation overnight at 37oC. 
 
Preparation of Ribosome Nascent Chains for L8C   
 Transcription templates were generated from linear DNA and amplified from a PCR kit 
(Takara). The 5’ primer of this reaction was located at the trc promoter (5’ CTGAAAT 
GACGTGTTGACA ATTAACATCCGG-3’) in the pTrc 99A, while the reverse primers were 
designed in different lengths of amino acids of Kcv containing 30aa, 40aa, 50aa, 60aa, and 
70aa, respectively without a stop codon in the sequence. S-30 extract was provided from C41 
(Woolhead et al., 2006). The PCR products were purified by a Quick PCR purification Kit 
(invitrogen). These PCR products were used in in vitro transcription/ translation reactions. The 
reaction is composed of total volume at 25 µL; 10 µL translation premix, 2.5 µL Amino acids 
(exclude methionine), 7.5 µL S-30 extract (MW 35,000), 1 µL Antisense oligonucleotide or 
ssrA 200 ng/ml, 2.5 µL Linear DNA, and radiolabelled [35S] Met. These components were 
incubated at 37oC for 30 minutes and left on ice for 5 minutes. The reactions of 30aa, 40aa, 
50aa, 60aa, and 70aa were overlaid on 100 µL 0.5 M sucrose cushion and centrifuged at 
100,000 rpm in the TLA-100 rotor for 6 minutes at 4oC.  Supernatants of all reactions were 
carefully aspirated and then the pellets resuspended with 8 µL RNC buffer, 1 µL RNaseA, and 
1 µL EDTA (5 mM final volume).  Later, the reactions were transferred to a fresh eppendorf, 
followed by incubation at 26oC for 10 minutes and 10 µL protein gel sample buffer was added. 
Thereafter, the samples were boiled at 65oC for 10 minutes and 10 µL of the sample was run 
on SDS-PAGE gel, the gel washed with destaining solution for an hour, gel dried with the dryer 
machine at 65oC for 1.5 hours before being placed over the cassette in the dark room and 
developed into a film overnight (as desirable resolution) with the Kodak X-Omat. 
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Polymerase Chain Reaction (Regular Amplified PCR)     
 dsDNA sequence of interest was amplified by desirably designed forward and reverse 
oligonucleotide primers (Appendix) .   The proper restriction sites are required for digestion in 
forward and reverse primers.  All primers in this project were purchased from Integrated DNA 
technologies, Inc.  The plasmid of interest as the template and components were prepared on 
ice in thin-walled PCR tubes. The regular PCR program is shown below:   
   
10x DNA polymerase buffer       10 µL   
 dNTP mix (2.5 mM each: dATP,dCTP,dGTP,dTTP)      8 µL   
 Forward primer (100 pMol)             1 µL   
 Reverse primer (100 pMol)            1 µL   
 dsDNA (Template) ~ 100ng/ µL        1 µL   
 Ex Taq DNA polymerase        0.5 µL  
Nucleus free water                bring up to 100 µL 
 
 PCR reactions were undergone using the Applied Bioscience 2720 thermal cycler in 
stand program as following:         
   
Temp Step Time Cycle 
94oC Initial 1 minute   1 Cycle 
94oC Denaturing 30 seconds  
56oC Annealing 30-60 seconds   30 cycles 
72oC Elongation 1 minute  
72oC Final Elongation 8 minutes  1 cycle 
4oC  Hold  Hold  
   
 The standard conditions for PCR can be appropriately set with the melting temperature 
of the interest primers. Generally, the optimal annealing temperature is approximately 5oC 
lower than the lowest melting temperature of the designed primers. When the PCR condition 
was completed, the products were purified by a PCR clean-up Kit (Invitrogen, PureLinkTM) and 
were run on a 1% agarose gel to confirm whether the obtained products were the correct 
molecular weight.  
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SOC Media for E.coli S-30 Extract Preparation      
 0.05% (w/v) NaCl, 0.5% Yeast Extract, 2% (w/v)Tryptone, 10 mM MgCl2,                 
10 mM MgSO4, 20 mM Glucose. The components were mixed together and put through a 
sterilised filter. The SOC media stocks were kept in the freezer until further use.  
   
 
Preparation of E.coli S-30 Extract        
 C41(DE3) cells from a frozen glycerol stock were streaked on an LB-agar plate and 
grown overnight at 37OC. From the plate, two single colonies were picked to be inoculated 
separately in the 5 mL LB-broth and grown overnight at 37OC with the shaker at 300 rpm. The 
following day, both two 5 mL were merged to inoculate the 500 mL SOC media. The culture 
was grown at 37OC with the shaker at 300 rpm until it reaches A600-0.8. At this step, 1 litre of 
ice was slowly added to the culture and centrifuged at 10,000 rpm for 10 minutes at 4OC. The 
supernatant was removed and the pellets were resuspended in 100 mL of Buffer 1 and 
centrifuged again at 10,000 rpm for 10 minutes at 4OC.  The supernatant was then discarded 
and the pellet resuspended in 100 mL of the Buffer 1 and recentrifuged for 10 minutes at 4OC. 
The pellet was collected by removing the supernatant and the cell was weighed and 
resuspended in Buffer 2 to a final concentration 0.5 g/mL. After that, lysozyme (100mg/mL 
stock) was then added to a final concentration of 1mg/mL. Following 15 minutes incubation 
on ice, the suspension cell was disrupted through a French press at 8,000 psi. Disrupted cells 
were centrifuged at 17,000 rpm for 30 minutes at 4OC. The supernatant was maintained and 
treated with 0.15 volumes of Run-out premix at 26OC for 70 minutes. Following the treatment, 
the extract eliminated the contaminant by dialysing 3 times using a Slide-A-Lyzer Dialysis 
Cassette 3500 MWCO in Buffer 3 for approximately 1 hour each. For the final step, the extract 
was centrifuged at 10,000 rpm at 4OC for 10 minutes and aliquoted to 1 mL and immediately 
snap frozen in the liquid Nitrogen and to be stored at -80OC. 
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In vitro Transcription/Translation in E.coli S-30 Extract translation 
 
The translation components were mixed in the E.coli transcription/translation system 
in the standard protocol of Dr. Cheryl Woolhead (approximately 25 µL).  Each translation 
reaction was added as outlined in the information below. 
 
 
Component Volume 
Translation premix                     10   µL 
1 mM each L-amino acid               
(without methionine) 
                           2.5 µL 
Linear DNA (~100 ng/ µL)                             2.5 µL 
E.coli  S-30 extract                             7.5 µL 
[35 S] methionine                             10 µCi 
5 µg/µl of anti-ssrA 
oligonucleotide  
                              1 µL 
             (5’- TTAAGCTGCTAAAGCGTAGTTTTCGTCGTCGTTTGCGACTA-3’) 
        Total volume 2.5 µL   
 Following the incubating reaction at 37OC for 30 minutes, the reaction was quenched 
by chilling on ice for 5 minutes. The sample was run on a SDS-PAGE gel, followed by the 
autoradiography analysis. 
 
Translation Premix Stock         
 137.5 mM HEPES (pH7.5), 520 mM K Glu, 68.75 mM NH4OAc, 48.25 mM MgOAc, 
4.25 mM DTT, 3 mM ATP, 2 mM each rNTPs, 6.25 ug/mL creatine Kinase, 200 mM creatine 
phosphate, 444 ug/mL E.coli  tRNA, 2 mM IPTG, 60 mg/mL PEG 8000, 170 µM folinic acid,  
1.6 mM cAMP 
 
 
 
 
 
44 
 
PEGylation Assay  
 PEGylation assay was initially started with S-30 in vitro transcription/translation 
reaction in total volume at 25 µL individually with truncation linear DNA, such as 30aa, 40aa, 
50aa, 60aa, and 70aa, respectively.  The reactions were centrifuged by being placed over 100 
µL of 0.5 M sucrose cushion for 6 minutes at 100,000 rpm at 4oC in TLA-100 rotor (Beckman). 
In this step, the pellets contained the ribosome bound nascent chains. The pellets were gently 
pipetted up and down for resuspending in 60 µL PEG buffer (20mM HEPES (pH 7.2), 100 mM 
NaCl. 5 mM MgCl2 and 50 µM DTT). Next, the samples were divided into equal volume at 30 
µL of each reaction into two fresh eppendorf tubes, including tube number 1 for an additional 
30 µL PEG-MAL (1mg/100 µL; PEG-MAL/ PEG buffer) and tube number 2 as a control 
containing 30 µL of PEG buffer only. The samples were then chilled on ice for two hours. 
Consequently, 5 µL of 100 mM DTT was added to quench the reaction and left at room 
temperature for 10 minutes. With each reaction, 600 µL of NaOAc (pH 4.7) was added and 
600 µL of 2% CTAB and incubated on ice for 15 minutes to precipitate the ribosome nascent 
chains. Then all samples were centrifuged at 14,000 rpm for 15 minutes at room temperature. 
Each supernatant was removed and the pellet remained and 1mL of acetone was added and 
chilled on dry ice for 10 minutes, then the samples were centrifuged at 14,000 rpm at 4oC for 
10 minutes. The pellets were heated to remove acetone at 50oC for 10 minutes. Thereafter, 
15 µL of 1 mg/ml RNAseA in distilled H20 were added to the tube then incubated at room 
temperature for 10 minutes. Following this, 15 µL of sample buffer was added into each 
sample and boiled with the heat block at 65oC for 10 minutes. Finally, all samples both of 
PEGylation and Non-PEGylation were run on the SDS-PAGE gels, the gels washed with the 
proper destaining solution (400 mL Methanol, 70 mL Acetic acid, and 530 mL distilled water), 
then dried for 1.5 hours and the process developed into a film overnight with the Kodak X-
Omat. 
  
Investigation of ribosome nascent chain protein interaction in the 1st TM domain 
by chemical cross-Linking assay using 1,6-Bismaleimidoheane (BMH) and immuno-
precipitation  
 To start the experiment, the ribosome nascent chains were generated by increasing 
four times the components of S-30 in vitro transcription/translation in the final volume at         
100 µL. The intermediate lengths were prepared individually from linear DNA containing 30aa, 
40aa, 50aa, 60aa, and 70aa. Next, the individual reaction was divided into two portions in 
ultracentrifugation tubes; 7 µL (A) and 93 µL (B) in the total 10 reactions.  All reaction tubes 
were placed over 100 µL of 0.5 M sucrose cushion. Following this, the reactions were 
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centrifuged in a TLA-100 rotor (Beckman) at 100,000 rpm for 6 minutes. In this step, before 
cross-linking with 1,6-Bismaleimi-doheane (BMH) investigation, the ribosome nascent chains 
were generated. A portion of the pellets (A) were mixed with 8 µL of RNC buffer,                              
1 µL RNase A (1 mg/mL ddH20) and 1 µL of 5 mM EDTA and incubated at 26oC for 10 minutes. 
The samples (A) were heated in 2X Tricine sample buffer at 65oC for 5 minutes.  After cross-
linking with BMH investigation, the pellets (B) were resuspended in 88 µL of 1 mM BMH in      
1 mM DMSO and incubated at 30oC for 15 minutes. Cross-linking reactions were terminated 
by the addition of 10 µL of 1 M DTT and then incubated at room temperature for 15 minutes. 
At the end of cross-linking reaction, the fresh tubes (B-new; 30aa,40aa.50aa.60aa, and 70aa) 
7 µL of cross-linked products were added then mixed well with 8 µL of RNC buffer, 1 µL RNase 
A (1 mg/mL ddH20) and 1 µL of 5 mM EDTA and incubated at 26oC for 10 minutes. All samples 
(B-new) were heated in 2X Tricine sample buffer at 65oC for 5 minutes, whereas the remaining 
samples then had the 9 µL of cold 100% TCA added to precipitate the pellets which were then 
incubated on ice for 20 minutes and centrifuged at 14,000 rpm at 4oC.  The upper parts of the 
samples were aspirated to get pellets for use in Immunoprecipitation assay. The TCA pellets 
were kept in the -20 freezer until further use. The 65oC heated (A-B new) samples (before/after 
cross-linking) were run on a SDS-PAGE gel, the gel was then washed with the proper 
destaining solution (400 mL Methanol, 70 mL Acetic acid, and 530 mL distilled water) then the 
gel was dried for 1.5 hours and the process developed into a film overnight with the Kodak           
X-Omat.  
  
Investigation of ribosome nascent chain protein interaction in the 1st TM 
domain by chemical cross-linking assay using Bis (sulfosuccinimidyl) 
suberate: BS3 and immunoprecipitation   
 Like the previous cross-linking assay using BMH, cross-linking using BS3 was 
performed. The ribosome nascent chains were generated by increasing four times the 
components of S-30 in vitro transcription/translation in total volume at 100 µL.                                      
The intermediate lengths were made from each linear DNA, including 30aa, 40aa, 50aa,          
60aa, and 70aa.  Then, each reaction was divided into two portions in ultracentrifugation tubes; 
7 µL (called A) and 93 µL (called B) in total 10 tubes of both. All reaction tubes were placed 
over 100 µL of 0.5 M sucrose cushion. The reactions were centrifuged in a TLA-100 rotor 
(Beckman) at 100,000 rpm for 6 minutes. This step was before cross-linking with lysine 
cross- linker (BS3) investigating in the ribosome nascent chains. The aliquot of the pellets 
(called A) was mixed with 8 µL of RNC buffer, 1 µL RNase A (1mg/mL ddH20) and 1 µL of         
5 mM EDTA and incubated at 26oC for 10 minutes. The samples (A) were heated in 2X Tricine 
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sample buffer at 65oC for 5 minutes. After cross-linking with BS3, the pellets (called B) were 
resuspended in 88 µL of 1 mM BS3 in RNC buffer and incubated on ice for 2 hours. Cross-
linking reactions were terminated by adding 5 mL of 1M Tris (pH8.0) and then incubated at 
room temperature for 15 minutes. At the end of the cross-linking reaction, the fresh tubes of  
7 µL of cross-linked products (called B-new; 30aa,40aa.50aa.60aa, and 70aa) were added 
then mixed well with 8 µL of RNC buffer, 1 µL RNase A (1 mg/mL ddH20) and 1 µL of 5 mM 
EDTA and incubated at 26oC for 10 minutes. All samples (B-new) were heated in 2X Tricine 
sample buffer at 65oC for 5 minutes, whereas cold 9 µL of 100% TCA was then added to the 
remaining samples to precipitate the pellets and incubated on ice for 20 minutes and 
centrifuged at 14,000 rpm at 4oC.  The upper parts of samples were aspirated to get the pellets 
to be used in Immunoprecipitation assay. The TCA pellets were kept in the -20oC freezer until 
further use. The 65oC heated (A-B new) samples (before/after cross-linking) were run on a 
SDS-PAGE gel, the gel washed with the proper destaining solution (400 mL Methanol, 70 mL 
Acetic acid, and 530 mL distilled water) dried for 1.5 hours over the dryer machine and the 
process developed into a film overnight with the Kodak X-Omat.  
     
Investigation of ribosome nascent chain protein interaction in the 1st TM 
immunoprecipitation (IP) Assay of Cross-linked products   
 The cross-linked pellets were resuspended in 50 µL of solubilisation buffer (235 µL 
Trix buffer (23% Glycerol, 333 mM Tris base, 26 mM EDTA pH8), 157 µL of 10% SDS, and   
8 µL of 100 mM Phenylmethane Sulfonyl Fluoride (PMSF), mixed well by vortex and heated 
to dissolve the remaining at 95oC for 5 minutes. Afterward, 1 mL of cold low-salt RIPA buffer 
was added (150 mM NaCl, 50 mMTris pH 8, 1% IGEPAL CA-63, 0.5% Deoxycholic acid and 
0.1% SDS), respectively.  Then, the samples were isolated by centrifugation at 14,000 rpm for 
10 minutes at 4oC. 1 mL of supernatants were collected from the samples and then divided 
into 2 fresh tubes for the addition of antibodies; either anti-L23 or another one for anti-SRP54 
(SRP protein, homologous to the prokaryotic Ffh) and followed by incubation on ice for 2 
hours. For the preparation of hydrate protein-A sepharose, 0.1 g of beads were added into a 
facol tube and washed in 10 mL of water and continued washing in 10 mL of cold low-salt 
RIPA buffer. After the washing step, 500 µL of low-salt RIPA buffer was added to resuspend 
the beads, 30 µL washed beads were added in each reaction and slowly rotated in the cold 
room (4oC) for 30 minutes. To harvest the incorporated pellets by spinning the beads at 5,000 
rpm for 1 minute at 4oC, the supernatant was then removed, and the bead pellets washed 3 
times; twice with 1 mL of high-salt RIPA and once in 1 mL low-salt RIPA buffer.  Finally, 15 µL 
of 1X Tricine sample buffer was added to the bead pellets, mixed by vortex for 10 seconds 
and boiled at 95oC for 5 minutes, and the whole samples run, except the residue, to the Tricine 
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SDS-PAGE gel and the same previous steps of the electrophoresis analysis performed.  
       
Mutagenesis           
 The experiment was the first mutagenesis of the Kcv wild type by replacing cysteine to 
leucine at position 8 (L8C) and a reverse primer to construct a cysteine was made.                            
The replacement of a cysteine was to be performed in the correct sequence.  The reverse 
primers were designed to replace three site lysine residues in the ‘L8C’, mainly K29 to 
Isoleucine, K46/47 to methionine. An individual single methionine constructed M15L and 
M15/23/26L was made by the same standard protocol (Appendix).  The mutagenesis was 
carried out by following the instructions of the QuickChange Lightning Site-Directed 
Mutagenesis Kit (Statagene, California, USA). Typically, in each reaction containing 5 µL of 
10X reaction buffer, 1 µL of dsDNA template (Kcv WT, L8C or replacement other interest 
residues), 1.25 µL 125 ng) of forward and reverse primer (diluted from the stock 10x to be 
~100 pmol), 1 µL of dNTP mix, 1.5 µL of QuickSolution reagent, ddH2O added to bring up the 
total volume to 50 µL, and then 1 µL of QuickChange Lightning Enzyme. The replacement 
mutagenesis was used as the regular PCR recycling program. However, the annealing 
temperature for proper mutagenesis was at 60oC.  Next, PCR products were transformed to 
DH5α purified plasmid DNA by QIAprep Spin Miniprep Kit (Qiagen, Germany). The construct 
in the Kcv sequence was confirmed by DNA sequencing and Services, Medical Science 
Institute, School of Life Science, University of Dundee, Scotland, UK. 
 
Polymerase Chain Reaction (Regular amplified PCR) for Site-Directed mutagenesis 
 PCR reactions were undergone using the Applied Bioscience 2720 thermal cycler in 
stand program as follows:         
   
Temp Step Time Cycle 
94oC Initial 1 minute   1 Cycle 
94oC Denaturing 30 seconds  
58oC Annealing 30-60 seconds   30 cycles 
72oC Elongation 1 minute  
72oC Final Elongation 8 minutes  1 cycle 
4oC  Hold  Hold  
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PCR products of single mutagenesis were added with 1 µL of the restriction enzyme DNP1 
for 1 hour at 37oC.  The Dpn enzyme will digest methyl groups on the backbone of the parental 
DNA molecules.  1 µL of the final reaction is introduced to transform with 50 µL of DH5α.  A 
single colony is picked for inoculation with LB media at 37oC.  overnight and plasmid DNA is 
prepared using a Miniprep Kit as described previously and run on a 1% agarose gel to check 
whether it is the correct molecular weight. The plasmid DNA sequence was confirmed by DNA 
sequencing and Services, Medical Science Institute, School of Life Science, University of 
Dundee, Scotland, UK. 
 
Polyacylamide Gel Electrophoresis and Radio-autography    
 The proteins of interest were radio- labelled [ 35S]  Met as described previously in the 
translation/ transcription method.   After running the samples, the slab SDS- PAGE gels were 
flushed with destaining solution, dried with the Gel dryer for 70- 80 minutes at 57- 60oC, the 
dried gel fixed in the cassette, followed by the x- ray film put over the dried gel ( only the red 
light in the dark room). Developing times for the films varied from 16-72 hours. 
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RESULTS 
 
In order to experimentally assess the early stage of the folding event of the potassium 
channel Kcv during synthesis, previous research has suggested that the topological 
assessment is one of the most efficient techniques to distinguish effectively the protein folding 
in some types of the membrane proteins, including these potassium channels. Based on the 
theoretical hallmark region of this fast biogenesis, observation of the mechanism should begin 
first with the transmembrane domains which manifest a helical structure inside the ribosome 
which has been newly synthesised. Essentially, most proteins kinetically fold naturally from N-
terminus to C-terminus. Hence, we initially carried out the single cysteine mutagenesis near 
the border of the first transmembrane domain, (the N-terminus of Kcv at position 8) making a 
replacement from a leucine to a cysteine called ‘(L8C),’  
In the basic principle, cysteine is the key residue for mass-tagging (site specific) to 
determine the topological protein structure by band-shift. With the L8C translation system, the 
mRNA truncators which lack stop codons were translated and radio-labelled [35S] Met in the 
cell-free system, or the prokaryotic S-30 in-vitro expression system. In the intermediate 
translation products, post-translational modification techniques were then employed to 
determine the secondary & tertiary structures of the nascent chain by PEGylation which can 
give an indication of whether the polypeptide chain is in folded, compact form or in an unfolded, 
conformation and followed by the final investigation was further ensured again by cross-linking 
assay, respectively. The truncated peptides were generated from the ribosome nascent chain 
complex (RNCs) by changing the selective amino acid sequence of the L8C. Throughout the 
in vitro system, we were able to investigate the L8C. This is the shortest potassium channel 
consisting of 94 amino acids (aa) with two transmembrane domains, typical C-terminus region 
nearly embedded into the membrane, and a central glycosylation site (Fig.14A-B). A cysteine 
mutagenesis relies on its remarkable property and also incorporates the specific sites in the 
Kcv (WT) sequence for the post-translational modification (Fig. 14C).               
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Kcv gene (WT) 
 
MLVFSKFLTRTEPFMIHLFILAMFVMIYKFFPGGFENNFSVANPDKKASWIDCIYFGVTTHSTVGFGDILPKTTGAKLCTIAHIVTVFFIVLTL 
 
 
Engineered Cysteine (Constructed Cysteine at position 8, Kcv L8C) 
 
MLVFSKFCTRTEPFMIHLFILAMFVMIYKFFPGGFENNFSVANPDKKASWIDCIYFGVTTHSTVGFGDILPKTTGAKLCTIAHIVTVFFIVLTL 
 
Cysteine null mutant 
 
MLVFSKFLTRTEPFMIHLFILAMFVMIYKFFPGGFENNFSVANPDKKASWIDSIYFGVTTHSTVGFGDILPKTTGAKLVTIAHIVTVFFIVLTL 
 
X – Transmembrane domain, X– Glycosylation site 
 
Figure 14:  The schematic diagrams of PBCV-1, Kcv protein in the lipid membrane. Transmembrane 
domains 1 and 2 (TM1/2) are formed by a regulatory central domain containing a conserve (TXGXGD) 
sequence (14A). The full amino acids sequence of Kcv the TM1 & TM2 (14B), (pore region, selectivity 
filter sequence); and the sequences of wild type/engineered Cysteine (L8C) of the Kcv genes (14C), 
are highlighted respectively. 
 
PEGylation assay to investigate the L8C nascent chain in the ribosome exit tunnel  
The PEGylation technology is widely used as a chemical modification technique to 
specifically site PEGylate target via a cysteine free residue (Lu & Deutsch, 2001) that also can 
be applied to examine the interface structure of the nascent peptide chain within the ribosome 
tunnel by accessibility of the large molecule thiol reagent.  In this technique, a single 
replacement cysteine (L8C) was introduced in the protein as a cysteine marker that can be 
modified by labelling with the methoxypolyethylene glycol maleimide (PEG-MAL).  
The PEG-MAL is a large thiol molecule ~5 kDa inaccessible through the ribosome 
tunnel which has an average diameter of 15 Å. Therefore, the PEGylation will not occur if the 
cysteine is inside the ribosome tunnel (Fig.15A). By comparison, for the PEGylation with a 
sulfhydryl group on cysteine side chain to be successful, the PEG-MAL thiolate must be 
outside the ribosome tunnel (Fig.15B).  
(TM1) (TM2) 
(TM1) (TM2) 
(TM1) 
(TM2) 
(14C) 
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In addition, the reaction causes the PEG-MAL to actively form irreversible thioester 
bonds with the sulfhydryl groups on a single cysteine residue, or C-S linkage between cysteine 
and PEG-MAL will be formed. Hence, the PEGylation of L8C will add 5 kDa to the molecular 
weight of the nascent chains of translation products. The distance connected by the nascent 
chain from the PTC to the exit of the tunnel not only depends on the number of amino acid 
residues, but also on the structures of the peptide chain. 
 
 
 
 
 
 
 
 
 
Figure 15:  Schematic diagram of the PEGylation reaction with methoxypolyethylene glycol maleimide 
(PEG-MAL), the nascent chain buried cysteine marker inside the ribosome that is not PEGylated (15A).  
In contrast (15B), illustrates when the nascent chain gets longer, the marker is released from outside 
the ribosome tunnel and can be thiolated by PEG-MAL referring to a PEGylated formation.  
 
After confirmation of the cysteine engineered sequence, the dsDNA was amplified to 
linear DNA using a PCR reaction.  By changing the reverse primers to give an intermediate 
length requirement to 30aa, 40aa, 50aa, 60aa and 70aa respectively, eventually five interest 
truncators (30-70aa) were created (Fig. 16A). The linear DNA without a stop codon was then 
introduced to a coupled transcription/translation system using a prokaryotic 30-S lysate in vitro 
expression system.  The translation was radio- labelled by [ 35S]  Met to generate the ribosome 
nascent chain complex (RNCs) intermediates. All translation products were then split into two 
portions, the first half was treated in 1mM PEG buffer; as a control (non-PEG-MAL); and 1mM 
PEG-MAL (with PEG-MAL) was added to the other half, then chilled on ice for two hours. The 
nascent chains were then analysed by SDS-PAGE in the post-translational modification using 
PEGylation technique. 
(15A) (15B) 
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The PCR reaction showed that the five bands of the truncated linear DNA of each 
length that had a cysteine substituted at position 8 ( L8C) , gradually increased in molecular 
weight to the correct size as expected on a 1%  agarose gel ( Fig.  16B) .  Following this, the 
truncators of linear DNA in vitro which were transcribed, translated and incorporated with tRNA 
in the ribosome. These truncated DNA then generated the ribosome nascent chain complexes 
(RNCs) accurately, both in their size & different lengths, which were experimentally bound to 
the ribosome as various translation intermediates. 
Consequently, the obtained transcription/ translation products are used further for 
PEGylation analysis (Fig.  16C) .  As the control, the non- treatment PEG-MAL bands present 
only the translation nascent chains slightly increased in their various sizes and lengths ( Fig. 
16D1) .  The PEGylation images of L8C show that the cysteine marker would be effectively 
PEGylated at the lengths of the nascent chain.  Although the size of the bands on the SDS-
PAGE gel increased as expected, multiple unexpected bounds are apparently seen in each 
lane potentially due to mis- starting translation at alternative methionine residues in the N-
terminus region. PEGylation analysis, in the shortest lengths 30-40aa, however, do not show 
the PEGylation.  In regard to efficiency of the adduct bands a negligible PEGylation can be 
seen appearing within 50aa in an original x- ray film of the process, but it might fade out after 
scanning. As a result, it still has not presented a clear shift band from this intermediate length 
(Fig.16D2). However, we suspected that the PEGylation would occur around 50aa from a tiny 
adduct band where a possible cysteine marker ( L8C)  becomes exposed from the ribosome 
tunnel. If the PEGylated band reaches the ribosome at 50aa, the L8C nascent chain would be 
approximately a 42aa bridge from the distal tunnel up to the peptide transference centre 
(PTC). In theory, throughout the ribosome exit tunnel to the PTC can host a full helical nascent 
chain roughly 60aa.   From these initial L8C PEGylated results, we were inspired to further 
probe the findings with the other experimental strategies involved. 
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Figure. 16: The schematic diagrams show that the truncators of linear DNA were generated from a 
single forward primer and by changing the reverse primers, the interest truncator lengths were achieved 
by the PCR program. The linear DNA lacks a stop codon to maintain the nascent peptide inside the 
ribosome. To ensure PCR products quality control, the obtained linear DNA truncators were run on a 
1% agarose gel (16A). The transcription of linear DNA to mRNA was synthesised corresponding to the 
production of peptide intermediates of 30-70aa to be installed with RNCs in the prokaryotic S-30 in vitro 
transcription/translation system (16B). All RNCs were generated, radio-labelled [35S] Met and separated 
on a 4-12% SDS-PAGE gel (16C).   
 For the PEGylation analysis, the intermediate lengths translation products were 
allocated into two portions; the first half was treated in 1mM PEG Buffer, as a control (without 
PEG-MAL), and the second half was incubated in 1mM PEG-MAL (with PEG-MAL). The 
PEGylation assay was resolved on a 10-12% SDS-PAGE gel.  Eventually, the PEGylation 
images were presented without PEG-MAL treatment (Fig. 16D1), and also with PEG-MAL 
treatment, where the PEGylated formation of the nascent chains increased in size ~5kDa (Fig. 
16D2). 
 
 
 
D1 D2 
* ** ** 
PTC 
PEG-
MAL 
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L8C chemical cross-linking assay using BMH and incorporating cross-linked product 
for IP assay upon ribosome bound nascent chains  
 In this strategy, to monitor the secondary/tertiary structure, the cross-linking approach 
is introduced to specifically conjugate between two cysteines. These are L8C and 1,6-
bismalei-midohexane (BMH) (homo cysteine cross-linker). The reaction will occur between 
sulfhydryl groups of the nascent chain and BMH that will form the covalent bonds.  Following 
the cross-linking experiment, the immunoprecipitation (IP) technique is to be subsequently 
employed to identify the associated protein.   
 Radio-labelled [35S] Met translation reaction of 100 µL was applied as described 
previously (material and method section) and was used to generate the nascent chain with 
intermediate lengths of 30aa,40aa,50aa,60aa, and 70aa, respectively. The total translation 
products were treated in parallel both with and without BMH, then incubated on ice for 30 
minutes. A sample of the cross-linking experiment was allocated before treatment (-) without 
BMH as a control; and after treatment (+) with BMH followed by separation on a 4-12% bis-
tris gel, washed, dried, and X-rayed onto film in a dark room. In the associated experiment, 
the remaining cross-linked products were then precipitated with 100% TCA (denaturing 
condition) and used for immunoprecipitation experiments (IP). Each sample was split for two 
antibodies referring to ribosomal proteins; (L23) and (SRP54 homologue of Ffh), the first half 
had only anti-L23 added; and the other half with anti-SRP54 added then incubated on ice for 
2 hours, followed by the pull-down technique with the hydrate protein A-Sepharose. The IP 
samples were run on the 4-12% bis-tris gels, washed, dried, and X-rayed onto film in a dark 
room. Finally, both of the cross-linked and IP films were developed with the X-Omat machine 
after a week, however the IP films require at least two weeks. The individual sizes of the 
associated proteins were approximately 14.89 kDa (L23), and 48.5 kDa (SRP54), but coupled 
with a nascent chain, this will add approximately 3-7 kDa.    
 The cross-linking results show that the translated nascent chain peptides bands 
gradually increase in size from the lowest amino acid length (30aa) to the highest amino acid 
length (70aa) for both without (-) and with (+) BMH. The intermediates lengths of with +BMH 
show the weak bands corresponding to the size of the signal recognition particle protein 
(SRP54) from 60aa to 70aa. (Fig. 17A).  In comparison, these interaction bands can be clearly 
identified by immunoprecipitation assay (IP).  In regard to the L8C/L23 cross-linked bands, 
they can be precipitated with anti-L23 to approximately 22 kDa which is the size of ribosomal 
L23 when the nascent chains are 50-70aa (Fig. 17B). However, the presence of L8C/SRP54 
cross-linked bands are precipitated with anti-SRP54 indicating the SPR54 size to be about 
48-49 kDa with the strongest bands ranging from 50-70aa (Fig. 17C).  
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Figure 17:  Cross-linking assay of L8C was initially carried out in the prokaryotic S-30 in vitro 
transcription/translation system. The RNCs were synthesised and radio-labelled [35S] Met, the N-
terminus intermediates ranging from 30-70aa. The translation samples were split into two portions, to 
treat before (-) treatment with BMH as a control; and after treatment with (+BMH). Cross-linked samples 
were resolved on a 4-12% bis-tris gel (17A). Followed by the encompassed experiment, all sample 
cross-linked products were precipitated with 100% TCA and immunoprecipitated (IP) under denaturing 
conditions before being equally divided and treated with two antibodies; the first half incubated with 
anti-L23.  The anti-L23 precipitated the right size of ribosomal protein L23 at approximately 16 kDa and 
raised the molecular weight of other ribosomal proteins (17B). The other half was treated with the anti- 
SRP54, which indicated the adduct size of SRP54 to be above 49 kDa (17C). The immunoprecipitated 
samples were analysed on a 4-12% bis-tris gel. 
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Lysine mutagenesis (K29I/K46/47M) for investigating Kcv structure at the 1st 
transmembrane domain 
 Previous cross-linking experiments using the cysteine-cysteine cross linker, BMH, 
have been established to determine the potassium channel Kcv, during in vitro synthesis 
system. The BMH cross-linking determined only a single mutant cysteine (L8C) when probing 
the secondary and tertiary structure.  However, we would like to determine what the exact 
interacting protein in the exit ribosome tunnel specifically is. Therefore, we incorporated the 
analysis with another residue in the protein, called lysine-lysine cross-linker, BS3.  In order to 
achieve this experiment, we required only a single lysine in the first transmembrane segment. 
Then, we deliberately replaced the three lysine (K) residues which are located near the N-
terminus region with two selective amino acids; at position K29 with isoleucine ‘K29I’ and at 
the other two positions; K46 and K47 with methionines ‘K46/47M’ combined into the primary 
mutagenesis L8C.  In this “three lysine mutagenesis”, we aimed to keep only a specific lysine 
for cross-linking at position 6 to monitor topological structure and the folding feature in the first 
transmembrane at the N-terminus. Based on increasing the protein properties, the mutation 
at K29 with isoleucine was thought to increase hydrophobic ability in the first transmembrane 
domain as well as to enable determination of the SRP targeting interaction. Additionally, the 
two substitution sites of K46/47M were preferable in promoting the ability of radio-labelled  
[35S] Met in the protein which could be seen clearly on the SDS-PAGE gel. The dsDNA was 
confirmed as being the right sequence after the substitution process (Fig. 18A). To generate 
linear DNA, the dsDNA was amplified using PCR reaction to a different truncator by changing 
reverse primers to form the five intermediate lengths; 30aa, 40aa, 50aa, 60aa, and 70aa, 
respectively (Fig.18B). All intermediate lengths of ribosome nascent chains were synthesised 
in prokaryotic S-30 in vitro expression system (Fig. 18C), which is used to further scrutinise 
post-translational modifications such as cross-linking assay and immunoprecipitation as 
follows: 
 
 
Engineered Cysteine (L8C)   
MLVFSKFCTRTEPFMIHLFILAMFVMIYKFFPGGFENNFSVANPDKKASWIDCIYFGVTTHSTVGFGDILPKTTGAKLCTIAHIVTVFFIVLTL 
 
Lysine mutagenesis, K-replacement 3 sites at K29/I, K46/47M  
 
M LVFSKFCTRTEPFMIHLFILAMFVMIYIFFPGGFENNFSVANPDMMASWIDSIYFGVTTHSTVGFGDILPKTTGAKLVTIAHIVTVFFIVLTL  
 
(TM1) (TM2) 
30aa  50aa  40aa  60aa  70aa  
(TM2) (TM1) 
(18A) 
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 Figure 18:  The replacement of three lysines in the L8C sequence K29I/K46/K47M (18A), The 
truncated linear DNA of various lengths was generated from the PCR reaction by changing reverse 
primers that lack the stop codons in a plasmid DNA template. All intermediates lengths 30-70aa were 
separated on a 1% agarose gel for the quality control (18B). 
 
 
Figure 18C:  The RNCs of three lysines substitution K29I/ K46/47M were generated and radio-labelled 
[35S] Met, the various N-terminus intermediate lengths in prokaryotic S-30 in vitro expression system 
ranging from 30-70aa. All intermediates lengths were resolved on a 10-12% SDS-PAGE gel. Each 
intermediate length shows gradual increase in size containing extra bands. These translation products 
will be employed for the cross-linking assay and immunoprecipitation analysis.  
 
 
(18B) 
(18C) 
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Chemical cross-linking assay of lysine mutagenesis in Kcv (K29I/K46/47M) using BS3 
and incorporating cross-linked products for IP assay to investigate ribosome bound 
nascent chains  
The cross-linking using BMH was used in the previous experiment for investigating 
and analysing the protein interaction with the ribosomal proteins (L23 and SRP54) at the exit 
of the ribosome tunnel. Hence, in this experiment strategy we used another option. The lysine-
lysine cross-linker bis(sulfosuccinimidyl)suberate (BS3) to examine the interaction among 
nascent chains, and ribosomal proteins when lysine in the L8C sequence has been replaced 
at three sites; K29IK46/47M.  Therefore, the lysine marker is only available in the N-terminus 
region at site K6.  We examined the five truncated intermediate lengths varying from 30-70aa 
(at intervals of 10aa).  However, there are another two lysines available within the C-terminus 
region K72 and K77 in the full length, located in the region downstream and far from the first 
transmembrane domain which is not necessary to detect.  
In the concept of the experiment, the 6K (Lys) is a measured position for detecting the 
protein structure by forming free single lysine with BS3 and the two molecules are cross-linked. 
This experiment was initially carried out through the regular cross-linking protocol and their 
cross-linked products were introduced for precipitating with 100% TCA (denaturing condition) 
and followed by IP assay with two selective antibodies, including anti-L23 and anti-SRP54. 
Eventually, the samples were resolved on a 10-12% SDS-PAGE gel. The gels were well dried, 
put into a cassette and films developed. A cross-linking film was the first developed over-night, 
whereas the IP of cross-linked film was later developed for approximately a month.  
The cross-linking results reveal that the nascent chain intermediate bands gradually 
increased from the lowest amino acid (30aa) to the highest amino acid (70aa) of both non-
treated and treated with BS3, while the samples were treated with BS3 providing intensive back 
ground for all translation peptides over all intermediates. The interaction of the nascent chain 
and the ribosomal proteins cannot be seen while analysing with the cross-linking processes 
(Fig. 19A).  On the other hand, the immunoprecipitation (IP) anti-L23 bands reached the 
clearest from 50-70aa of about 22 kDa which indicate the size of ribosomal protein L23 (Fig. 
19B). Meanwhile the anti-SRP54 bands were present around the upper nascent chain 
peptides ranging from 50-70aa at about 50 kDa indicating the molecular weight of ribosomal 
protein SRP54 and showing the strongest signal from 60-70aa (Fig. 19C). 
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Figure 19:  Cross-linking assay of the L8C constructed of three lysines K29I/ K46/47M. The experiment 
was carried out in the prokaryotic S-30 in vitro transcription/translation system. Firstly, the protein was 
radio-labelled [35S] Met the N-terminus intermediates lengths ranging from 30-70aa (at intervals of 10aa). 
Following this, the cross-linking was carried out before treatment (-) without BS3, (as a control) and after 
treatment (+) with BS3.  The cross-linked samples were resolved on a 10-12% SDS-PAGE gel and 
developed onto the film over-night. The images of both treatments with BS3 (+) & without (-), indicate 
apparent translation products (Fig. 19A).         
 In a further associated experiment, the cross-linked products were precipitated with 
100% TCA (denaturing condition) and introduced for immunoprecipitation with two antibodies 
(IP), Each sample was split into two portions, the first half treated with anti-L23 and the other 
half treated with anti-SRP54, then both incubated on ice for two hours.  Afterwards, in order 
to obtain the RNCs, the reactions were pulled down with hydrate protein A-Sepharose. The 
protein pellets can participate with anti-L23 to increase to the size of ribosomal protein L23 
approximately 16 kDa (Fig. 19B). Whereas the protein treated with anti-SRP54 raised the 
adduct bands to ribosomal protein SRP54 (Fig. 19C), The samples were resolved on a 10-
12% SDS-PAGE gel and developed onto film for about a month. 
PTC 
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A single methionine mutagenesis to investigate the improvement results of the 
nascent chain in the ribosome exit tunnel  
 While doing several progressive post-translational modifications, we found that there 
were some extra bands existing in the translation products. Therefore, the bands of the 
nascent chain peptides in S-30 in vitro translation system are clearly required for various 
further analysis. As we well know, methionine is the first initial transcription amino acid, 
therefore it was absolutely essential to clarify what the main methionine is to transcribe mRNA. 
We first replaced only a single methionine at the site 15 with leucine (M15L), of both L8C and 
three lysines substituted (K29I/K46/47M) to their sequences in order to compare which is the 
proper mutagenesis to present a clear band on a SDS-PAGE gel.  At primary mutagenesis, 
the L8C contains four methionines in sequence at the positions; 1, 15, 23 and 26 (Fig. 20A), 
respectively, while three lysine substitutions (K29/I/K46/47M) contain six methionines at the 
positions; 1, 15, 23, 26, 46 and 47, respectively (Fig. 20B).     
  The findings of the linear DNA truncation (Fig. 20C), and the translation products in 
each intermediate length of these mutations unfortunately show the weaker translation in 
general. However, the specific nascent chain bands of the translation product are a little bit 
clearer (Fig. 20D). 
 
 
Engineered cysteine (L8C)   
MLVFSKFCTRTEPFMIHLFILAMFVMIYKFFPGGFENNFSVANPDKKASWIDCIYFGVTTHSTVGFGDILPKTTGAKLCTIAHIVTVFFIVLTL 
 
Replacement of a single methionine (M15L) into Engineered cysteine (L8C)        M15L-Cysteine 
MLVFSKFCTRTEPFMIHLFILAMFVMIYKFFPGGFENNFSVANPDKKASWIDCIYFGVTTHSTVGFGDILPKTTGAKLCTIAHIVTVFFIVLTL 
 
 
 
 
Engineered lysine, K-replacement 3 sites at K29/I/K46/47M 
M LVFSKFCTRTEPFMIHLFILAMFVMIYIFFPGGFENNFSVANPDMMASWIDSIYFGVTTHSTVGFGDILPKTTGAKLVTIAHIVTVFFIVLTL  
 
 
 
70aa  60aa  50aa  40aa  30aa  
(TM1) (TM2) 
(TM1) (TM2) 
(TM1) (TM2) 
L 
(20A) 
(20B) 
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Replacement of a single methionine (M15L) into Lysine mutagenesis,  
K-replacement 3 sites at K29/I/K46/47M         M15L-Lysine 
 
M LVFSKFCTRTEPFMIHLFILAMFVMIYIFFPGGFENNFSVANPDMMASWIDSIYFGVTTHSTVGFGDILPKTTGAKLVTIAHIVTVFFIVLTL  
 
 
Figure 20:  Diagram of two mutagenesis of replacement of a single methionine engineered to a single 
leucine at site 15; (i) L8C to M15L-Cysteine (20A), and (ii) replacement in single three lysines 
engineered (K29I /K46/47M) to M15L-Lysine (20B). 
 
 
 
 
Figure 20C:   The truncation of linear DNA, in which a single methionine was substituted instead of 
leucine at site 15 ( M15L)  of both M15L- cysteine ( L8C)  and M15L-  three lysine substitutions ( K29I 
/K46/47M) were made. The linear DNA of intermediate lengths is generated from the PCR reaction by 
changing reverse primers that lack stop codons in a plasmid DNA template and all intermediate lengths 
will be used for translation reactions. 
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Figure 20D: Comparison between RNCs of a single methionine mutagenesis at site 15 instead of 
leucine in both of the M15L-Cysteine (L8C) and M15L- three lysine substitutions K29I/K46/47M.The 
RNCs were generated and radio-labelled [35S] Met, the N-terminus intermediates lengths ranging from 
30-70aa (at intervals of 10 aa) in prokaryotic S-30 in vitro transcription/translation system. All translation 
samples were resolved on a 10-12% SDS-PAGE gel. Only translation products of M15L-Cysteine were 
selected to be used for PEGylation.  
 
PEGylation assay (M15L-Cysteine) to investigate the Kcv nascent chain in the 
ribosome exit tunnel  
 In order to get the improvement in the topological structure of the protein by a cysteine 
mass-tagging in position 8 of M15L-Cysteine (Fig. 20A), the PEGylation technique was carried 
out once again to observe the early protein folding in the first transmembrane domain through 
the shift bands on electrophoresis gels, which indicate the peptides have been mass tagged. 
Like the previous PEGylation assay, the standard translation reactions were prepared at 25µL. 
These reactions were split into two portions, the first half was incubated using 1mM PEG buffer 
as a control (without -PEG-MAL, see appendix); the second half incubated with 1mM PEG-
MAL (with +PEG-MAL) and incubated on ice for two hours. PEGylation samples were 
analysed on a 10-12% SDS-PAGE gel.        
The PEGylation analysis shows that the nascent chain peptides from 30-70aa have 
increased explicitly in size both as a control without treatment (-PEG-MAL, see in Fig. 21A) 
and containing (+PEG-MAL, see in Fig. 21B). In comparison, the shift-bands of the nascent 
(20D) 
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chains which are treated with the thiol reagent (+PEG-MAL), show a stronger signal from 50-
70aa if the nascent chain becomes longer which indicated that the PEGylation between the 
intra-molecular sulfhydryl-sulfhydryl linkage and possibly at the 50aa reached from the 
ribosome tunnel are conjugated. It implies that a cysteine marker (L8C) is released from the 
ribosome tunnel when measuring approximately 42aa from the exit tunnel to the peptide 
transfer centre (PTC). The PEGylation bands from 50-70aa display apparent detailed topology 
of the secondary protein in M15L-Cysteine mutagenesis (Fig. 21B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21:  PEGylation event of the replacement of a single methionine mutagenesis at site 15 to 
leucine; M15L-Cysteine (L8C). The RNCs were generated and radio-labelled [35S]Met, in the prokaryotic 
S-30 in vitro transcription/translation system with the N-terminus intermediate lengths ranging from 30-
70aa (at intervals of 10aa). The translation products were split into two portions, the first half incubated 
in 1mM PEG Buffer (without-PEG-MAL) as a control (21A), while the other half incubated in 1mM PEG-
MAL(+PEG-MAL). The PEGylated shift-bands clearly appear over the nascent chains varying from 50-
70aa (21B). The samples were resolved on a 10-12% SDS-PAGE gel. 
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Three single methionine mutagenesis to investigate the improvement in 
results of the nascent chain in the ribosome exit tunnel 
 In regard to the previous results of a single methionine mutagenesis M15L-Cysteine 
(L8C), some improvement was evident. In order to see if this could be improved more, further 
mutations were made. Therefore, an additional replacement of two single methionines to two 
leucines, which are located close to the first transmembrane domain, at the sites M23/26L 
were subsequently designed. After confirmation, the mutagenesis sequences are shown in 
(Fig. 22). The substitution of M15/23/26-Cysteine and M15/23/26-Lysine were incorporated 
into linear DNA through a PCR amplification reaction without the stop codons. Associated 
experiments, in vitro translation, cross-linking and immunoprecipitation assay were then 
carried out, respectively.  
 
 
 A single methionine (M15L) combined with engineered cysteine (L8C)        M15L-Cysteine 
 
MLVFSKFCTRTEPFMIHLFILAMFVMIYKFFPGGFENNFSVANPDKKASWIDCIYFGVTTHSTVGFGDILPKTTGAKLCTIAHIVTVFFIVLTL 
 
 Three single methionines M23/26 combined with M15L-Cysteine            M15L/23/26-Cysteine 
MLVFSKFCTRTEPFMIHLFILAMFVMIYKFFPGGFENNFSVANPDKKASWIDCIYFGVTTHSTVGFGDILPKTTGAKLCTIAHIVTVFFIVLTL 
 
 
A single methionine (M15L) combined with lysine mutagenesis, K-replacement 3 sites at    
K29/IK46/47M         M15L-Lysine 
 
M LVFSKFCTRTEPFMIHLFILAMFVMIYIFFPGGFENNFSVANPDMMASWIDSIYFGVTTHSTVGFGDILPKTTGAKLVTIAHIVTVFFIVLTL  
 
 
 Three single methionines (M23/26) combined with M15L-Lysine          M15L/23/26-Lysine 
M LVFSKFCTRTEPFMIHLFILAMFVMIYIFFPGGFENNFSVANPDMMASWIDSIYFGVTTHSTVGFGDILPKTTGAKLVTIAHIVTVFFIVLTL  
 
 
Figure 22: Diagram of replacement of three single methionines engineered to three leucines at three 
sites 15/23/26 in two Kcv mutagenesis; (i) L8C to M15/23/26L-Cysteine (22A), and (ii) eventually the 
presence sequence of three lysines engineered (K29I/ K46/47M) to M15/23/26L-Lysine (22B). 
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(TM1) (TM2) 
L L L 
70aa  60aa  50aa  40aa  30aa  
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Figure 22C: The truncation of linear DNA with the replacement of three single methionine to three 
leucines of two mutagenesis (i) L8C to M15/23/26L-Cysteine and (ii) K29I/K46/47M to M15/23/26L-
Lysine. The linear DNA was synthesised from the PCR reaction by changing reverse primers that lack 
stop codons in a plasmid DNA template. These truncated linear DNA will be introduced for further 
prokaryotic S-30 in vitro transcription/translation reaction. 
 
 
Figure 22D: The RNCs of replacement of single three methionines mutagenesis to three leucines in 
both two mutagenesis; (i) L8C to M15/23/26L-Cysteine and (ii) K29I/K46/47M to M15/23/26L-Lysine. 
The RNCs were generated and radio-labelled [35S] Met, the N-terminus in various intermediate lengths 
ranging from 30-70aa (at intervals of 10 aa) in the prokaryotic S-30 in vitro translation system.  All 
translation truncations were resolved on a 10-12% SDS-PAGE gel.  Consequently, selection of only the 
translation products of M15/23/26L-Lysine substitutions (K29I/K46/47M) will be used for another cross-
linking and IP assay. 
 
 
(22C) 
(22D) 
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Chemical cross-linking assay with BS3 and IP assay of Kcv mutagenesis 
M15/23/26L-Lysine upon ribosome bound nascent chains   
 In this experiment, we used a lysine-lysine cross linker, BS3 whose reaction occurs 
between the end of the reactive group of BS3 and the functional group of the engineered Kcv. 
To provide the protein for this experiment, L8C was substituted for three single lysines 
(K29I/K46/47M) and then, three single methionines replaced leucines at three sites 15, 23, 
and 26, respectively.  The combination mutagenesis is called ‘M15/23/26-Lysine’ (Fig. 22B).  
Three residues of lysine in the full sequence are available at three sites K6, K72 and K7, 
however the last two residues are most likely to be located close to the second transmembrane 
& C-terminus domain which was not necessary to determine. Hence, K6 (Lys) is a single lysine 
marker in the first transmembrane domain that is used to conjugate an amide-amide reaction.  
The replacement strategy of three methionines is designed to maintain only a single 
methionine at the first position of the sequence (Fig. 22B). Ideally, maintenance of only one 
methionine in the protein sequence is to elucidate if we can get the improvement of 
intermediate lengths on the SDS-PAGE gel. Furthermore, if we obtained this manifestation, 
the cross-linking experiment was started with 100 µL translation reactions, including five 
intermediate lengths; 30aa, 40aa, 50aa, 60aa, and 70aa, respectively. 
 All five reactions were carried out in two steps; before and after treatment with BS3. 
Each translation reaction was split into two portions, first 7 µL of reaction was overlaid on a 
sucrose cushion and centrifuged, with the supernatant removed before treatment (-) without 
BS3, and the remaining was overlaid on a sucrose cushion, centrifuged, the supernatant 
aspirated and 1mM BS3 added before incubation on ice for 2 hours after treatment (+) with 
BS3.  
Hereafter, each reaction was taken for after treatment with -BS3. Both treatments were 
purified on a 10-12% SDS-PAGE gel, while the remaining cross-linked products were 
precipitated with 100% TCA (denaturing condition). The pellets were then used for 
immunoprecipitation (IP). Each intermediate length reaction was divided into two equal 
portions for two antibodies. Either anti-L23 or anti-SRP54 were then incubated on ice for 2 
hours pulled down with hydrate protein A-Sepharose. The samples were resolved on a 10-
12% SDS-PAGE gel and developed onto film for about a month. IP bands were presented 
above the translation product; L23 molecule size at 14.89 kDa and SRP at 48.5 kDa.  The 
samples were resolved on a 10-12% SDS-PAGE gel.  
The cross-linking showed that each intermediate band (RNCs) slightly increased in 
size from the lowest amino acid length (30aa) to the highest amino acid length (70aa), The 
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nascent chains of non-treated (-BS3) and treated with (+BS3) were presented by size from the 
bottom of the gels. 
However, the samples which were treated with (+BS3) present the interacting peptide 
bands over two nascent chains from 60-70aa, which indicated SRP bands at about 62 kDa 
and other indigenous background bands (Fig. 23A).  While these cross-linked products were 
detected using immunoprecipitation (IP) with 2 antibodies, the RNCs/L23 cross-linked bands 
were precipitated with anti-L23 obviously displaying from 50-70aa of about 20 kDa, which is 
the size of ribosomal protein L23 (Fig. 23B).   
Whereas the RNCs/ SRP54 cross-linked were precipitated with anti-SRP54 indicating 
the bands over nascent chain peptides ranging from 50-70aa at about 49 kDa which is the 
size of ribosomal protein SRP54 (Fig. 23C). However, there are two remarkably strong bands 
from 60-70aa as well as other unexpected lower and upper background bands in existence. 
 
 
 
 
 
 
 
 
 
 
(23A) 
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Figure 23:  Cross-linking analysis of the M15/23/26L-Lysine was carried out in the prokaryotic S-30     
in vitro transcription/translation system. The RNCs were generated and radio-labelled [35S] Met, the N-
terminus intermediate lengths varying from 30-70aa (at interval 10aa). Cross-linking assay, each 
intermediate length was incubated before (-) treatment with BS3 as a control and after (+) treatment 
with BS3. The cross-linked samples were resolved on a 10-12% SDS-PAGE gel (23A). In an associated 
experiment, cross-linked products of all intermediate lengths were used for immunoprecipitation (IP). 
Each sample was split to be treated with two antibodies; the first half incubated with anti-L23 and the 
other half incubated with anti-SRP54, then chilled on ice for two hours. After that, the incubated antibody 
reactions were pulled down with hydrate protein A-Sepharose. The samples were resolved on a 10-
12% SDS-PAGE gel. The immunoprecipitation images show that the RNCs/anti-L23 were precipitated 
and raised to the ribosomal L23 at about 16 kDa, including other higher molecular weight of ribosomal 
proteins (23B), whereas RNCs/anti-SRP54 cross-linked can raise the strong intensity band of ribosomal 
protein SRP54 to be above 49 kDa, containing other unexpected lower/higher molecular weight of SRP 
proteins (23C). 
 
 
 
 
 
(23B) (23C) 
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DISCUSSION 
 
 Previous studies have been carried out in the ‘Woolhead’ lab to investigate the 
formation of secondary structure within the ribosome tunnel using the F0c protein from               
E. coli. The F0c is present in the bacterial inner membrane and is a short protein containing 
only 79 amino acids with two transmembrane domains, separated by a loop, with the short 
terminal. FRET analysis has revealed that the first transmembrane domain of F0c begins to 
fold inside the ribosome tunnel and forms a compacted nascent chain within the exit tunnel of 
the ribosome before leaving and subsequently binding to SRP for membrane targeting 
(Robinson et al., 2012) 
                                                                                        
              Further study from our group has shown this is not a regular event which occurs with 
every protein. The GPCR family is the largest group of transmembrane proteins comprising 
many diverse types of proteins, with the common theme being that each has seven 
transmembrane domains. Therefore, one of the GPCR members is preferable as a large 
membrane protein model for selection to ascertain the early protein folding. The human 
ortholog GPCR GPR35 is a plasma membrane receptor expressed in a wide variety of tissue 
and cell types. Recent work on the GPCR GPR35 has shown that the first transmembrane 
domain does not fold until it has reached the membrane translocation site at Sec61 in 
endoplasmic reticulum (ER) (Cherry, 2016 Unpublished).       
          
             However, my work which is presented here, is on the viral potassium channel, Kcv, 
which is a miniature protein (10.6 kDa) consisting of two transmembrane domains and 
resembling the common features of F0c as shown in the previous study by Robinson et al. 
(2012).  Furthermore, recently published work found that during both studies of in vitro and in 
vivo (in live bacteria) that the small protein domains which range in size 4-10 kDa have the 
early folding during translation while still inside the ribosome. The folding proteins possess 
three formational classes of secondary structures; α-helical, β-sheet, and mixed α+ β (Marino 
et al., 2016). Recent evidence on the co-translational folding event or folding during translation 
is still limited. However, from my experimental investigation using the post-translational 
modification, several example parts of the small model protein, Kcv, were obtained. The 
results of this project therefore reveal that the folding of Kcv should begin during translation 
within the ribosome due to the communication mechanism of the ribosome and the targeting 
transportation.  
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 In the Kcv typical structural arrangement, a total of 94 assigned amino acid residues 
modulate as an ion channel in different structural functions; S-helix (1-13aa), TM1 (14-32aa), 
Loop1 (33-49aa), P-helix (50-62aa), Filter 63-68aa), Loop2 (69-75aa) and TM2 (46-94aa), 
respectively. The main structure has helical transmembrane domains of approximately 18 
amino acids each that play vital roles in the interaction against the hydrophobic region in the 
lipid bilayer to span the pore and function as an ion channel (Tayefeh et al., 2009).   The 
experimental detail in each critical step of early folding investigation is shown below; 
   
Determining the secondary structure of the 1st transmembrane domain in 
ribosome bound nascent chain complexes using PEGylation assay  
For the reference, contribution of amino acid inside the ribosome tunnel, Lu and 
Deutsch (2005) suggests that the nascent chain could be accommodated inside the ribosome 
tunnel depending on the structures; an α-helix ~1.5 Å per residue while an extended 
conformation (stretched chain) ~ 3.4 Å per residue. Based on the evidence from PEGylation, 
findings indicate that the first transmembrane domain of Kcv appears to be completely 
compacted in secondary structure in the ribosome tunnel, most likely in an alpha helical 
conformation. The PEGylation analysis of engineered cysteine (L8C) indicates the primary 
clue of a tiny shift-band when the nascent chain reaches a length of around 50aa (Fig.16D). 
To confirm the PEGylation results (Fig.21), the experiment was presented with the explicit 
adduct bands from 50aa using the PEGylation method to probe combination mutagenesis of 
M15L-Cysteine (additional substitution M15L to L8C).   
 
An explanation of mass-tagging within the large ribosome is as follows:  the cysteine 
residue in Kcv (L8C) is gradually monitored from the PTC in each defined truncated length. If 
the nascent chain conformation of the Kcv (L8C) is approximately at 30aa length, the cysteine 
marker is at a position 22 residues from the PTC (where the centre of the top of the large 
ribosome is). This is located too deep within the ribosome tunnel and the thiol PEG-MAL 
molecule is too large to access through the narrow tunnel for mass-tagging.  However, when 
the nascent chains are at least 50aa, with the cysteine 42 residues from the PTC, the cysteine 
is released from the exit site and can actively conjugate with the PEG-MAL molecule as shown 
on an electrophoresis gel from truncated lengths 50-70aa. Therefore, structure inside the 
tunnel can be monitored by the timing of the PEGylation. And the PEGylation results can 
detect the primary transmembrane domain would begin to fold on the ribosome. On the other 
hand, it should be noted that we would expect the initial extra 13aa which is exposed from the 
ribosome nascent chain to be unfolded due to its N-terminus region.  
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Investigation of ribosome nascent chain protein interaction in the 1st TM domain 
using cross-linking assay and immunoprecipitation  
Upon exiting the ribosome tunnel Kcv is likely to interact with chaperones to guide it to 
the membrane. To determine this process two homobifunctional cross-linkers were used; 
cysteine-cysteine (BMH) and lysine-lysine cross-linker (BS3). Both cross-linkers demonstrated 
results that correspond to the PEGylation assays. In detail, the cross-linking results showed 
that the high truncated lengths have the adduct bands of cross-linked with the SRP54 
homologue Ffh (two truncated lengths 60-70aa). Indicating that the first transmembrane 
domain binds to SRP upon exiting the ribosome.  
A cross-linked band of ~50 kDa is just visible when it starts being released from the 
tunnel at approximately 60aa, providing further evidence of a compacted structure in the 
ribosome tunnel. To confirm the identity of this band an immunoprecipitation assay was used. 
The immunoprecipitation has introduced separately, two antibodies to distinguish the protein 
interaction, these were anti-L23 and anti-Ffh (SRP homologue of prokaryotes). The 
immunoprecipitation results found and confirmed the protein interaction between the nascent 
chain and ribosomal protein L23 and the targeting protein Ffh (SRP) varying from 50-70aa 
(Fig.10). The interaction between the nascent chain peptide and ribosomal protein (L23) and 
the signal recognition particle (SRP54 conserved part of SRP) is the universal principle of the 
beginning of protein targeting (Houben et al., 2005).  
BS3 used a different method by crosslinking lysine residues, to create a single targeted 
lysine, three endogenous lysines were replaced as follows (K29I/ K46/47M), leaving just K6 
which is the only lysine marker present in the N-terminus sequence to be monitored with the 
lysine of BS3.  Unfortunately, the cross-linking assay using BS3 cross-linker indicates only the 
bands of nascent chain lengths, but neither inefficient bands of ribosomal protein L23 nor the 
signal recognition particle SRP54 (Ffh) are visibly clear. However, initial folding in the first 
transmembrane can be predicted, accounting for the BMH induced adduct band on SDS-
PAGE gels starting around 50-60aa.  
 
To improve the reporter signal, three additional methionines were mutated into the Kcv 
sequence (M15/23/26L) combined with three single lysines mutagenesis (K29I/K46/47M 
+L8C) which resulted in an improvement of results both of cross-linking and immuno-
precipitation (IP) images in the same manner as shown in previous results. Interestingly, 
immunoprecipitation analysis of cross-linked products shows more explicit intensity of 
interaction in the height bands (50-70aa) both of anti-L23 and anti-Ffh (Fig.23). Therefore, it 
can be suggested that the three methionine mutagenesis incorporated into a previous 
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construction with only a single methionine available in the first transmembrane domain would 
enable the best observations and give insight into protein folding and eliminate the extra bands 
in the translation products. Altogether, this phenomenon can explain that a single methionine 
codon in a mRNA of defined truncated lengths would be insured for initial starting of the 
translation process and result in clearer bands in each sequential step of the experiment, 
including translation products, cross-linked products, and immunoprecipitation images. 
However, although we can gain clearer bands, we still cannot get a single band in the 
translation products as expected from the consecutive mutagenesis. 
 
The mutagenesis of Kcv for experimental purposes 
The mutagenesis relies on the amino acid position and properties for our experimental 
purposes. In this project, we carried out the construction of the three critical processes step 
by step. We can replace the amino acid residues of the subject matter interest based on its 
native properties.  First, a cysteine engineered (L8C) is used for the cysteine marker in the 
first transmembrane region for the PEGylation assay which is the proper site for conjugation 
with PEG-MAL and the results for further experiments. Second, three lysines engineered 
K29I/K46/47M for the cross-linking method show improvement only in the cross-linked 
immunoprecipitation assay.  Because of the amino acid residue properties, an isoleucine at 
position 29 is a non-polar side chain with hydrophobicity while two replacement methionines 
K46/47M which are for the increasing radio-labelling activity with a radioactive reagent,         
[35S] Met result in the increased capture of intensity bands in the X-ray film. Furthermore, these 
two methionine substitutions increase the hydrophobicity in the Kcv domain. Hence, in this 
lysine mutagenesis, improvements in the results of cross-linked immunoprecipitation are 
manifested. Third, three methionines mutagenesis M15/23/26L-Lysine are obtained from the 
combination with three single replacements and a single methionine remains from this 
mutagenesis for starting codon. Eventually, the improvement of the Kcv insertion studies was 
detailed using SDS-PAGE gels and autoradiography for analysis, this being the best approach 
to separate the small size protein. For better understanding of function, this mutagenesis could 
be used to monitor the role of Kcv function.  
     
The Kcv folding in prokaryotic (S30) in vitro transcription/translation system 
Much previous published work has supported this Kcv folding profile, that the 
sequential processes of the Kcv folding pathway initially is based on the prokaryotic (S30)       
in vitro transcription/translation expression system. For the coupling transcription/translation 
process to be sufficient and efficient, the supplements involve, for example, amino acids, 
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energy sources, nucleotides and salts (Nirenberg & Mattaei, 1961).  In vitro transcribed mRNA 
is employed for the reactions to be adequately radioactively labelled with Sulfur-35 radioactive 
reagent [methionine amino acid labelled] 35S-Met which can be detected by X-ray film, using 
an X-Omat developer, as an autoradiography trough when dried on a SDS-PAGE gel.  The 
ribosome nascent chains (RNCs) were installed from the truncated mRNA without the stop 
codons to prevent the nascent chain being released from the ribosome (Huter et al., 2017).  
 The translation is variable depending on environments and organisms, for example, 
the translation rates in vivo are faster than in vitro systems (Fedyukina & Carvagnero, 2011). 
However, the translation in the in vitro system can also be described in four main steps; 
initiation, elongation, termination, and recycling.  In regard to the synthesis rate of prokaryotic 
in vitro system, the ribosome translates mRNA into the amino acid sequence that is needed 
for the Kcv nascent chain to be synthesised at approximately 10-20 amino acid/second 
(Cabrita et al., 2016), whereby the different codons and structural elements in mRNA attributes 
determine the elongation rate and further proper folding. (Goldman et al., 2015).    
Generally, the classical hypothesis of protein folding process is that folding starts early 
from the secondary elements and is then followed by the tertiary structure which is formed by 
the compaction of the secondary structure (Kim & Baldwin, 1982). Regarding this principle of 
folding formation, we would expect that Kcv would have the early process of folding on the 
ribosome. During the translation of  Kcv, the evidence provided here suggests that the alpha 
helical transmembrane of Kcv initiates folding in the ribosome emerging from the ribosome 
tunnel. The communication of the nascent chain and ribosomal protein L23 and targeting 
protein (SRP54) correspond to the delivery pathway. Generally, if we give an outline of the 
Kcv transportation, we see that L23 is first seen by the nascent chain at 50aa in length, this is 
much later than with and extended peptide (~30aa). L23 contains an external affinity site for 
bacterial SRP, so the nascent chain is transferred between L23 and Ffh at ~60aa from the 
PTC (Kramer et al., 2002; Luirink & Sinning, 2004; Akopian et al., 2013).  
 Recruitment by SRP occurs as the transmembrane domain emerges from the 
ribosome tunnel.  The C-terminal M domain of Ffh contains a hydrophobic cleft that has 
numerous methionine residues that can be associated to the central part of the nascent chain 
signal. Also, the NG domain (GTPase domain) of Ffh can make a reciprocal contribution for 
binding to the signal of the exported nascent chain (Cross et al., 2009).   
The RNC/SRP complex then targets the Kcv towards the membrane. It is unknown if 
other membrane machinery is required for membrane integration or if this occurs 
spontaneously. 
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Conclusion 
In summary, this study has investigated if the first transmembrane domain of Kcv would 
fold in the ribosome tunnel during translation. Apparently, PBCV-1 Kcv is the shortest 
potassium channel protein composed of just 94 amino acids with two transmembrane 
domains.  It is possible that the initial folding process and conformation of small protein 
domains occurs in the ribosome rather than in the plasma membrane. According to the 
evidence from previous research, this may be a cellular mechanism to prevent protein mis-
folding in the hydrophilic cell cytosol. Regarding my results using PEGylation and chemical 
cross-linking, both approaches show the same event of the first TM domain compacting early 
in the ribosome exit tunnel. Therefore, based on our previous studies, it is possible to support 
the hypothesis that the small membrane proteins such as Kcv and F0c appeared to follow this 
folding pathway of initial transmembrane domain compaction inside the ribosome tunnel 
before insertion into the membrane. This does not appear to be consistent with larger proteins 
such as the seven transmembrane domains GPCRs. This mechanism could be indicative of 
an easier insertion route for small hydrophobic proteins such as Kcv and F0c, which do not 
require the many protein component and membrane co-factors for targeting and insertion that 
larger proteins such as GPCRs do. 
        
Future Direction           
In order to carry out on an extensive investigation of the viral potassium channel Kcv, 
high potential techniques to elucidate other questions of the proteins underlying structures and 
functions should be examined further.  NMR spectroscopy is the effective machine to 
investigate the folding of three-dimension structure such as the N-terminus region from which 
we can select the most interesting model to incorporate with interest sources.  X- ray 
crystallography can be used to solve both structure and function.  Kcv structure will be 
determined in terms of its various parts in more detail, such as cations crossing the channel 
between the outside- inside of the cell, the conduction pathway, the backbone structure, 
Oxygen atom or Hydrogen atom.   Furthermore, mutagenesis for changing the properties of 
amino acids in the Kcv should be focused on, for instance the hydrophobicity of the 
transmembrane domains and the effect of protein targeting by replacing some amino residues. 
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APPENDIX 
 
Information of Kcv gene 
Nucleotide Sequence   
UniProtKB - Q84568 (KCV_PBCV1) 
Protein 
 
ATGTTAGTGT   TTAGTAAATT    TCTAACGCGA   ACTGAACCAT  TCATGATACA    TCTCTTTATT  
CTCGCAATGT  TCGTGATGAT   CTATAAATTC   TTCCCGGGAG  GGTTCGAAAA  TAACTTCTCT  
GTTGCAAACC  CGGACAAAAA  GGCATCATGG  ATAGATTGTA   TATACTTCGG   AGTAACGACA 
CACTCTACTG  TCGGATTCGG   AGATATACTG   CCAAAGACGA  CCGGCGCAAA  GCTTTGTACG  
ATAGCACATA  TAGTAACAGT    GTTCTTCATC    GTTCTAACTT   TATGA 
 
Kcv Amino Acid Sequence (original sequence) 
M L V F S K F L T R T E P F M I H L F I L A M F V M I Y K F F P G G F E N N F S V A N P D K K A S 
W I D S I Y F G V T T H S T V G F G D I L P K T T G A K L V T I A H I V T V F F I V L T L  
X – Transmembrane Domain,    X – Glycosylation site 
 
Primers used to synthesise the linear DNA Fragments     
 Forward primer for PCR reaction to synthesise linear DNA for S-30 extract in vitro 
transcription/translation system using the pTrc99A primer   5’           3’;  5’-CTG AAA TGA 
GCT GTT GAC AAT TAA TCA TCC GC-’3 
  
Table 2: Reverse primers list and their sequences for PCR reaction to generate truncation 
linear DNA (Kcv engineered Cysteine)   
Experiment Primer Name Primer Sequence 5’     3’ 
Translation/PEGylation/ 
Cross- linking Assay/IP 
Assay 
Kcv 30aa rev. ‘GAA TTT ATA GAT CAT CAC GAA 
CAT TGC GAG’ 
Kcv 40aa rev. ‘AGA GAA GTT ATT TTC GAA CCC 
TCC CGG GAA’  
Kcv 50aa rev. ‘CCA TGA TGC CTT TTT GTC CGG 
GTT TGC AAC’ 
Kcv 60aa rev. ‘TGT CGT TAC TCC GAA GTA TAT 
ACA ACT TAT’ 
Kcv 70aa rev. ‘CAG TAT ACT TCC GAA TCC GAC 
AGT AGA GTG’ 
20aa 
40aa 
60aa 
80aa 
94aa 
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Table 3: Cysteine mutagenesis (L8C) and primers 
Experiment Gene 
Replacement  
Primer Name Primer Sequence 5’           3’ 
Translation/ 
PEGylation/ 
Cross-linking 
Assay/ 
IP Assay 
Leu                Cys 
(CTA)         (TGC) 
L8C Fwd. `GTT TAG TAA ATTTTG CAC GCG 
AAC TGA ACC’ 
L8C Rev. ‘GGT TCA GTT CGC GTG CAA AAT 
TTA CTA AAC’ 
 
Engineered Cysteine (L8C) 
M L V F S K F C T R T E P F M I H L F I L A M F V M I Y K F F P G G F E N N F S V A N P D K K A 
S W I D S I Y F G V T T H S T V G F G D I L P K T T G A K L V T I A H I V T V F F I V L T L  
 
Cysteine null mutant 
M L V F S K F L T R T E P F M I H L F I L A M F V M I Y K F F P G G F E N N F S V A N P D K K A S 
W I D S I Y F G V T T H S T V G F G D I L P K T T G A K L V T I A H I V T V F F I V L T L  
 
 
Table 4:  Single three lysines mutagenesis (three sites; K29I/K46/47M) and primers 
Experiment Gene 
Replacement 
Primer Name Primer Sequence 5’            3’ 
Translation/ 
Cross Linking Assay 
Lys                Ile 
(AAA)       (ATA) 
K29I Fwd. ‘GCA ATG TTC GTG ATG ATC 
TAT ATA TTC TTC CCG G’ 
K29I Rev. ‘CCG GGA AGA ATA TAT AGA 
TCA TCA CGA ACA TTG’ 
Lys                Met 
(AAA)       (ATG) 
K46/47M Fwd. ‘GTT GCA AAC CCG GAC ATG 
ATG GCA TCA TGG ATA G’ 
K46/47M Rev. ‘CTA TCC ATG ATG CCA  TCA 
TGT CCG GGT TTG CAA C’ 
 
Replacement of three residues into three sites of lysine in (L8C) 
 
 
M L V F S K F C T R T E P F M I H L F I L A M F V M I Y KF F P G G F E N N F S V A N P D K K A  
S W I D S I Y F G V T T H S T V G F G D I L P K T T G A K L V T I A H I V T V F F I V L T L  
 
 
 
I M M 
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Table 5:  Primers of a single methionine mutagenesis (Position M15L) Kcv gene from the 1st 
engineered Cysteine (L8C) 
Experiment Gene 
Replacement 
Primer Name Primer Sequence 5’           3’ 
Translation/PEGylation Met                Leu 
(ATG)         (TTG)   
M15L Fwd. ‘CGC GAA CTG AAC CAT  TCT 
TGA TAC ATC TCT TTA TTC 
TCG’ 
M15L Rev. ‘CGA GAA TAA AGA GAT GTA 
TCA AGA ATG GTT CAG TTC 
GCG’ 
        
Replacement in only one sight of methionine instead of leucine in three lysines substitution 
(K29I/K46/47M) 
 
M L V F S K F C T R T E P F L I H L F I L A M F V M I Y K F F P G G F E N N F S V A N P D M MA S 
W I D S I Y F G V T T H S T V G F G D I L P K T T G A K L V T I A H I V T V F F I V L T L  
 
 
Table 6:  Primers of single methionines mutagenesis (M23/26L) Kcv gene combination 
between the 1st  engineered lysine (K29I/K46/47M) and  the engineered methionine  (M15L)  
Experiment Gene Replacement Primer Name Primer Sequence 5’           3’ 
Translation/Cross -
linking Assay/IP 
Assay 
Met                Leu 
(ATG)          (TTG)   
M23/26L Fwd. ‘CTT TAT TCT CGC ATT GTT 
CGT GTT GAT CTA TAA ATT 
CTT CC’ 
M23/26L Rev. ‘GGA AGA ATT TAT AGA TCA 
ACA CGA ACA ATG CGA GAA 
TAA AG’ 
 
        Combination between single three methionines with three sights of leucine in three 
lysines substitution (K29I/K46/47M) 
 
 
M L V F S K F C T R T E P F L I H L F I L A L F V  LY M F F P G G F E N N F S V A N P D M M A S 
W I D S I Y F G V T T H S T V G F G D I L P K T T G A K L V T I A H I V T V F F I V L T L  
 
 
M 
M 
M M 
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Agarose gel electrophoresis 
Agarose gel electrophoresis was regularly used as part of the project, such as for DNA 
purification, quality control of PCR products as well as for the analysis of control digestion of 
the cloning products. Tris-acetate/EDTA. (TAE) was applied to dissolve the agarose powder. 
The concentration of agarose is defined depending on the fragment lengths. Hence, the Kcv 
intermediate lengths that are lower than 500bp are preferably used for the agarose 
concentration between 1-2% (w/v).  For the preparation of agarose gel, agarose powder was 
dissolved in 1xTAE buffer and heated in the microwave at medium power for about 1 minute. 
The melted gel was left to cool down a little and 0.5 µg/mL of ethidium bromide was added. 
This was followed by the heated gel being poured into a combined casting and electrophoresis 
system. A comb was immediately placed into the gel during heating to allow all wells to set.  
After the gel is perfectly set, the chamber was filled with the TAE buffer and the comb was 
removed gently. The DNA samples were mixed by adding Loading Dye (6X) and loaded into 
an individual well on the gel. Then, the DNA markers either a 100bp or 1 kb (Promega) were 
mixed with ddH20 before loading into the gel. The fragment samples were resolved at 80 volts 
for approximately 40 minutes and following this, visualised under UV light (the Bio-Rad, 
Molecular Imager ® Chemidoc XRS System). 
 
Tricine-SDS-PAGE Gel  
 Acrylamide/bis-acrylamide (AB) 30% 
  Buffer Gel: 3M Tris-Hcl pH 8.45  
  APS: 10% Solution (Ammonium Persulfate)     
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Table 7: Components for preparing a 3 layered Tricine SDS-PAGE gel (10-12%) (2 gels) 
Component 1st Layer-Separating 2nd Layer-Spacer 3rd Layer-Stacking 
AB (30%) 8.4 mL 0.66 mL 0.534 mL 
Buffer Gel pH 8.45  4.95 mL 0.67 mL 1 mL 
Glycerol 1.95 mL - - 
Water - 0.68 mL 2.46 mL 
APS10% 100 µL 10µL 40 µL 
TEMED 10 µL 1µ L 4 µL 
Time to leave gels set 
up 
15 min 20 min 60 -90 min 
 
- To make up two gels, the 1st layer should be poured into clean glass plates until the gels 
well is set enough and then followed by each other step. 
 
Buffers used in the experiments 
  
TAE Buffer (pH 8.0) 
40 mM Tris                           
20 mM Acetic acid                       
1 mM EDTA                 
(stored at room temperature) 
          
PEG Buffer                             
20 Mm HEPES pH 7.2,                   
100 mM NaCl,                       5 
mM MgCl2  
           
Solubilisation buffer stock (Kept in room temperature) 
235 µL Trix buffer; 23% Glycerol, 333mM Tris base, 26 mM EDTA pH 8.0                 
157 µL of 10% SDS               
8 µL of 100 mM Phenylmethane Sulfonyl Fluoride (PMSF)     
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RIPA Buffer (Low Salt)                           
150 mM NaCl                           
50 mM Tris pH 8.0             
1% IGEPAL CA-630                                  
0.5% Deoxycholic acid                      
0.1% SDS 
 
HS-RIPA Buffer (High Salt)                         
500 mM NaCl                           
50 mM Tris pH 8.0             
1% IGEPAL CA-630                      
0.5% Deoxycholic acid                     
0.1% SDS  
 
  
  
